1
|
Meng HP, Zhao HF, Zhang XN, Xu TW, Guo CY. [Splenic metastasis of endometrial cancer 8 years after treatment: report of a case]. Zhonghua Bing Li Xue Za Zhi 2024; 53:404-406. [PMID: 38556829 DOI: 10.3760/cma.j.cn112151-20231023-00291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/02/2024]
Affiliation(s)
- H P Meng
- Department of Graduate School, Hebei North University, Zhangjiakou 075000, China
| | - H F Zhao
- Department of Pathology, Hebei General Hospital, Shijiazhuang 050051, China
| | - X N Zhang
- Department of Pathology, Hebei General Hospital, Shijiazhuang 050051, China
| | - T W Xu
- Department of Graduate School, Hebei North University, Zhangjiakou 075000, China
| | - C Y Guo
- Department of Pathology, Traditional Chinese Medicine Hospital of Xianxian, Cangzhou 062250, China
| |
Collapse
|
2
|
Zhang ZC, Zhao HF, Sun Z, Li Y, Zhong ML, Wang BH, Jiang XZ. Tripartite motif-containing 9 promoted proliferation and migration of bladder cancer cells through CEACAM6-Smad2/3 axis. J Cell Commun Signal 2023:10.1007/s12079-023-00766-7. [PMID: 37249822 DOI: 10.1007/s12079-023-00766-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2022] [Accepted: 05/04/2023] [Indexed: 05/31/2023] Open
Abstract
Studies have shown that tripartite motif-containing (TRIM) family proteins function as E3 ubiquitin ligases and play essential roles in cancer biology. In the present study, we validated a contribution of TRIM9 to bladder cancer progression. 296 patients derived from The Cancer Genome Atlas (TCGA) database and 22 clinical specimens were included, in which accumulated TRIM9 correlated with the poor prognosis and higher relapse in bladder patients. In vitro, TRIM9 promoted bladder cancer cells Biu-87 and T24 cell proliferation and migration. Meanwhile, overexpression of TRIM9 reduced the chemosensitivity in Biu-87 and T24 to mitomycin C (MMC) and gemcitabine (GEM). As an underlying mechanism, we found that TRIM9 stimulated carcinoembryonic antigen 6 (CEACAM6) upregulation, which further facilitated Smad2/3-matrix metalloproteinase 2 (MMP2) signaling activation both in vitro and in vivo. Those results indicated that TRIM9 facilitated bladder cancer development and chemoresistance by CEACAM6-Smad2/3 axis. TRIM9 and its associated molecules could be a potential diagnostic indicator and therapeutic target in bladder cancer.
Collapse
Affiliation(s)
- Zhao-Cun Zhang
- Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong Province, China
| | - Hai-Feng Zhao
- Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong Province, China
| | - Zhuang Sun
- Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong Province, China
| | - Yi Li
- Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong Province, China
| | - Ming-Lei Zhong
- Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong Province, China
| | - Bao-Hai Wang
- Department of Urology, Liangshan People's Hospital, Jining, Shandong Province, China
| | - Xian-Zhou Jiang
- Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong Province, China.
| |
Collapse
|
3
|
Yang XW, Zhao HF, Liu XJ, Bi MP, Hu PY, Shi BB, Lou M. [Effect of methylene blue labeling on therapeutic effect and prognosis of gastric cancer patients in D2 radical gastrectomy under laparoscope]. Zhonghua Yi Xue Za Zhi 2023; 103:431-435. [PMID: 36775267 DOI: 10.3760/cma.j.cn112137-20220708-01515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
Objective: To investigate the effect of methylene blue tracing on the effect of surgical resection and the prognosis of gastric cancer patients in D2 radical surgery under laparoscope. Methods: In this retrospective cohort study, 160 patients with advanced gastric cancer who underwent surgical treatment in Xinxiang Central Hospital, the 4th Clinical College of Xinxiang Medical College from January 2016 to January 2019 were selected for retrospective analysis. Among them, 84 patients underwent laparoscopic D2 radical gastrectomy for gastric cancer combined with methylene blue labeling operation (labeling group), and the other 76 patients underwent only laparoscopic D2 radical gastrectomy for gastric cancer (control group). The difference of intraoperative and postoperative recovery, lymph node dissection, and postoperative 3-year cumulative survival rate between the two groups were analyzed. Results: The age of patients in the labeled group and the control group were (64.9±7.8) and (66.0±8.3) years old, respectively (P=0.389); And the male patients accounted for 61.9% (52 cases) and 55.3% (42 cases), respectively (P=0.394); The operation time in the labeled group was (218.5±19.6) min, which was shorter than that in the control group (230.1±17.4) min (P<0.001). There was no significant difference between the labeled group and the control group in the amount of bleeding during operation, the time of anal exhaust after operation, the time of eating after operation, the time of hospitalization after operation, and the average diameter of lymph nodes (P>0.05). The total number of dissected lymph nodes, D1 lymph nodes and D2 lymph nodes in the labeled group were significantly higher than those in the control group (all P values<0.05). The operative complication rate in the labeled group was 11.9% (10 cases), which was lower than that in the control group (25.0%, 19 cases) (P=0.032); There was no statistical significance in 3-year cumulative survival rates of patients between the labeled group (61.9%) and the control group (52.6%) (χ2=3.46,P=0.065). Conclusion: The use of methylene blue tracing in laparoscopic D2 radical surgery for gastric cancer is beneficial to reduce the operation time, improve the lymph node clearance rate, and reduce surgical complications.
Collapse
Affiliation(s)
- X W Yang
- Department of General Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China
| | - H F Zhao
- Department of General Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China
| | - X J Liu
- Department of General Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China
| | - M P Bi
- Department of General Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China
| | - P Y Hu
- Department of General Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China
| | - B B Shi
- Department of General Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China
| | - M Lou
- Department of General Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China
| |
Collapse
|
4
|
Zhao HF, Zhang Y, Dang LX, Liang JL, Chen SX, Guo Z, Li YL, Zu RR, Gui XD, Wei YP, Song Y. [Analysis the influence factors of treatment free remission outcome with chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitors]. Zhonghua Yi Xue Za Zhi 2022; 102:1523-1529. [PMID: 35692068 DOI: 10.3760/cma.j.cn112137-20220112-00074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To explore the related factors affecting the outcome of treatment free remission (TFR) in patients with chronic myeloid leukemia (CML). Methods: Clinical data of CML patients with automatic discontinuation of tyrosine kinase inhibitor (TKI) from the CML cooperative organization of Henan province between June 2, 2013 to March 27, 2021 and the follow-up time was ≥ 6 months were retrospectively analyzed. Log-rank test was used for univariate analysis and Cox proportional risk regression model was used for multivariate analysis. Results: A total of 135 patients were enrolled, and 69 patients (51.1%) were femal and 66 patients (48.9%)were male. Median age was[M(Q1,Q3)] 49 years (38, 58)at discontinuation.Before discontinuation, 72 patients (53.3%) were on treatment with second-generation TKI, 63 patients (46.7%) were on treatment with IM, 17patients (12.6%) had a history of TKI reduction/withdrawal;median duration of treatment was months 84 (68, 108) for all patients;median time of TKI treatment to DMR was months 12(8, 26);median duration of DMR was months 65 (54, 84), and 9 patients (6.7%) had unsustained DMR.The median follow-up time was months 16(6-96), 35 patients (25.9%) lost MMR at a median months 3(1-22), overall estimated TFR was 74.1%.The univariate analysis results showed that:second-generation TKI was used, the time of TKI treatment to DMR was ≤12 months, DMR duration time ≥48 months, had sustained DMR, without TKI reduction/withdrawal history were favorable factors affecting of TFR in patients with TKI discontinuation (all P<0.05).The TFR rate of the second-generation TKI therapy group was significantly higher than the IM therapy group (81.9% vs 65.1%, P=0.019).The multivariate analysis results showed that second-generation TKI treatment[RR=0.451, 95%CI (0.227-0.896), P=0.023] and had sustained DMR [RR=0.120, 95%CI (0.053-0.271), P<0.001] were the protective factors of TFR in patients with TKI discontinuation. Conclusions: Treated with second-generation TKI and had sustained DMR are the protective factors of TFR in patients with TKI discontinuation.The CML patients who had sustained DMR more≥48 months before TKI discontinuation showed a better TFR.
Collapse
Affiliation(s)
- H F Zhao
- Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - Yanli Zhang
- Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - L X Dang
- Department of Hematology, the first Affiliated Hospital of Nanyang Medical College, Nanyang 473000, China
| | - J L Liang
- Department of Hematology, Sanmenxia Central Hospital, Sanmenxia 472000, China
| | - S X Chen
- Department of Hematology, Pingdingshan Second People's Hospital, Pingdingshan 467000, China
| | - Z Guo
- Department of Hematology, Zhengzhou People's Hospital, Zhengzhou 450000, China
| | - Y L Li
- Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - R R Zu
- Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - X D Gui
- Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - Y P Wei
- Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - Yongping Song
- Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| |
Collapse
|
5
|
Zhao HF, Lou M, Bi MP, Yang XW, Hu PY, Liu JL. [Molecular mechanism of miR-369-3p regulating hepatocellular carcinoma cell proliferation and apoptosis by targeting ACTN4]. Zhonghua Zhong Liu Za Zhi 2021; 43:1156-1163. [PMID: 34794217 DOI: 10.3760/cma.j.cn112152-20191107-00719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the effect of miR-369-3p targeting ACTN4 expression on proliferation and apoptosis of hepatocellular carcinoma cells. Methods: Real-time quantitative polymerase chain reaction (RT-qPCR) and western blot were used to detect the expression levels of miR-369-3p and ACTN4 in hepatocarcinoma tissues and adjacent tissues. MiR-369-3p mimics, miR-negative control (NC), si-ACTN4, and si-NC were transfected into hepatocellular carcinoma MHCC97H cells by liposome method. Cell proliferation was detected by 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-dipheny-ltetrazolium bromide (MTT) assay. Flow cytometry was used to detect cell cycle and apoptotic rates. The dual luciferase reporter assay was used to verify the targeted regulation of ACTN4 by miR-369-3p. Western blot was used to detect the expressions of cyclin D1, p21, Bcl-2 and Bax. Results: The expression level of miR-369-3p in liver cancer tissue was lower than that in adjacent tissues [(0.46±0.04) vs (1.00±0.08), P<0.001)], while the expression level of ACTN4 was higher than that in adjacent tissues [mRNA (3.12±0.29) vs (1.01±0.09); protein (0.61±0.06) vs (0.25±0.03), P<0.001]. Overexpression of miR-369-3p significantly decreased the cell viability[(0.71±0.06) vs (1.26±0.11), P<0.001)], increased cell apoptosis rate [(20.16±2.11)% vs (6.25±0.64)%, P<0.001], increased the proportion of cells in G(1) phase [(31.14±3.36)% vs (51.56±5.23)%, P<0.001], decreased the proportion of cells in S phase [(32.44±3.56)% vs (14.33) ±1.45)%, P<0.001], increased the levels of p21 and Bax protein (P<0.001), and decreased the levels of cyclin D1 and Bcl-2 protein (P<0.001). Inhibition of the expression of ACTN4 significantly reduced the cell viability [(0.78±0.07) vs (1.24±0.12), P<0.001], increased the apoptosis rate [(6.58±0.66)% vs (18.32±1.82)%, P<0.001], increased the proportion of cells in G(1) phase [(48.69±4.21)% vs (30.33±3.01)%, P<0.001], decreased the proportion of cells in S phase [(36.21±3.42)% vs (18.54±1.61)%, P<0.001], increased the protein levels of p21 and Bax (P<0.001), and decreased the levels of cyclin D1 and Bcl-2 protein (P<0.001). Compared with the miR-369-3p+ pcDNA group, overexpression of ACTN4 increased the proliferation ability of hepatocellular carcinoma MHCC97H cells at 72 hours of culture[(1.12±0.11) vs (0.68±0.06), P<0.001], significantly reduced the proportion of cells in G(1) stage [(38.81±3.24)% vs (51.80±4.57)%, P<0.001], significantly increased the proportion of S-phase cells [(31.65±3.11)% vs (15.69±1.44)%, P<0.001], decreased cell apoptosis rate [(13.86±1.37)% vs (22.69±2.24)%, P<0.001], increased protein expressions of cyclin D1 and Bcl-2 (P<0.001), decreased the protein expressions of p21 and Bax (P<0.001). Conclusion: MiR-369-3p can induce cell cycle arrest in G(1) phase, inhibit the proliferation and promote apoptosis of liver cancer cells by regulating the expression of ACTN4.
Collapse
Affiliation(s)
- H F Zhao
- Department of Oncology, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical University, Xinxiang 453000, China
| | - M Lou
- Department of Oncology, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical University, Xinxiang 453000, China
| | - M P Bi
- Department of Oncology, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical University, Xinxiang 453000, China
| | - X W Yang
- Department of Oncology, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical University, Xinxiang 453000, China
| | - P Y Hu
- Department of Oncology, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical University, Xinxiang 453000, China
| | - J L Liu
- Department of Oncology, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical University, Xinxiang 453000, China
| |
Collapse
|
6
|
Gui RR, Li Z, Zu YL, Wang J, Liu YY, Zhang BL, Yu FK, Zhang Y, Zhao HF, Wang P, Song YP, Zhou J. [CMV-CTL for treatment of refractory CMV infection in 17 patients following alternative donor hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi 2021; 42:865-868. [PMID: 34788929 PMCID: PMC8607013 DOI: 10.3760/cma.j.issn.0253-2727.2021.10.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- R R Gui
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - Z Li
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - Y L Zu
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - J Wang
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - Y Y Liu
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - B L Zhang
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - F K Yu
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - Yanli Zhang
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - H F Zhao
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - P Wang
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - Y P Song
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| | - J Zhou
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Zhengzhou 450008, China
| |
Collapse
|
7
|
Pan ZJ, Zhang ZC, Jiang XZ, Zhao HF, Wang S, Han RY, Tian J. Juxtaglomerular Cell Tumor: A Rare Cause of Hypertension. Urology 2021; 158:3-4. [PMID: 34536412 DOI: 10.1016/j.urology.2021.08.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Revised: 08/17/2021] [Accepted: 08/29/2021] [Indexed: 11/16/2022]
Affiliation(s)
- Zhong-Jian Pan
- Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Zhao-Cun Zhang
- Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Xian-Zhou Jiang
- Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Hai-Feng Zhao
- Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Shuo Wang
- Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Ruo-Yan Han
- Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Jun Tian
- Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
| |
Collapse
|
8
|
Xu PP, Ding BJ, Li MJ, Liu JP, Liu L, Xia A, Liu WQ, Zhou KS, Zhao HF, Zhou H, Song YP. [Hereditary coagulation factor XIII deficiency: three cases report and literaure review]. Zhonghua Xue Ye Xue Za Zhi 2021; 42:256-258. [PMID: 33910314 PMCID: PMC8081941 DOI: 10.3760/cma.j.issn.0253-2727.2021.03.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- P P Xu
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, China
| | - B J Ding
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, China
| | - M J Li
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, China
| | - J P Liu
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, China
| | - L Liu
- Department of Hematology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - A Xia
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, China
| | - W Q Liu
- Department of Intensive Care Units, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - K S Zhou
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, China
| | - H F Zhao
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, China
| | - H Zhou
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, China
| | - Y P Song
- Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, China
| |
Collapse
|
9
|
Qin Z, Zhang J, Chen L, Liu SX, Zhao HF, Mao HM, Zhang HY, Li DF. Anti-inflammatory active components of the roots of Datura metel. J Asian Nat Prod Res 2021; 23:392-398. [PMID: 32189519 DOI: 10.1080/10286020.2020.1739660] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/16/2019] [Accepted: 03/04/2020] [Indexed: 06/10/2023]
Abstract
One new phenolic glycoside, methyl 3,4-dihydroxyphenylacetate-4-O-[2-O-β-D-apisoyl-6-O-(2-hydroxybenzoyl)]-β-D-glucopyranoside (1), together with 10 known compounds (2-11), were isolated from the roots of Datura metel. The structures of these compounds were elucidated on the basis of their spectroscopic data. Furthermore, the in vitro anti-inflammatory activities of compounds 1-11 were evaluated.[Formula: see text].
Collapse
Affiliation(s)
- Ze Qin
- The Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China
| | - Jin Zhang
- The Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China
| | - Liang Chen
- The Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China
| | - Shu-Xiang Liu
- The Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China
| | - Hai-Feng Zhao
- The Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China
| | - Hui-Min Mao
- The Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China
| | - Hong-Yang Zhang
- The Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China
| | - De-Fang Li
- School of Integrated Traditional Chinese and Western Medicine, Binzhou Medical University, Yantai 264003, China
| |
Collapse
|
10
|
Li Z, Zhang Y, Zhou J, Zhao HF, Yu FK, Gui RR, Zu YL, Song YP. [Chronic myelogenous leukemia in children complicated with retroperitoneal fibrosis: a case report]. Zhonghua Xue Ye Xue Za Zhi 2021; 41:776. [PMID: 33113613 PMCID: PMC7595874 DOI: 10.3760/cma.j.issn.0253-2727.2020.09.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Z Li
- Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Institute of Hematology, Zhengzhou 450008, China
| | - Yanli Zhang
- Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Institute of Hematology, Zhengzhou 450008, China
| | - J Zhou
- Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Institute of Hematology, Zhengzhou 450008, China
| | - H F Zhao
- Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Institute of Hematology, Zhengzhou 450008, China
| | - F K Yu
- Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Institute of Hematology, Zhengzhou 450008, China
| | - R R Gui
- Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Institute of Hematology, Zhengzhou 450008, China
| | - Y L Zu
- Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Institute of Hematology, Zhengzhou 450008, China
| | - Y P Song
- Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Institute of Hematology, Zhengzhou 450008, China
| |
Collapse
|
11
|
Zhou H, Xu PP, Li MJ, Liu L, Ding BJ, Liu JP, Zhao HF, Zhou KS, Song YP. [MYH9 related disease with thrombocytopenia: a case report and literature review]. Zhonghua Xue Ye Xue Za Zhi 2020; 41:334-335. [PMID: 32447941 PMCID: PMC7364931 DOI: 10.3760/cma.j.issn.0253-2727.2020.04.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/29/2019] [Indexed: 11/05/2022]
Affiliation(s)
- H Zhou
- Department of Hematology, Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou 450008, China
| | - P P Xu
- Department of Hematology, Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou 450008, China
| | - M J Li
- Department of Hematology, Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou 450008, China
| | - L Liu
- Department of Hematology, Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou 450008, China
| | - B J Ding
- Department of Hematology, Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou 450008, China
| | - J P Liu
- Department of Hematology, Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou 450008, China
| | - H F Zhao
- Department of Hematology, Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou 450008, China
| | - K S Zhou
- Department of Hematology, Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou 450008, China
| | - Y P Song
- Department of Hematology, Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou 450008, China
| |
Collapse
|
12
|
Wang WH, Wang F, Zhao HF, Yan K, Huang CL, Yin Y, Huang Q, Chen ZZ, Zhu WY. Injectable Magnesium-Zinc Alloy Containing Hydrogel Complex for Bone Regeneration. Front Bioeng Biotechnol 2020; 8:617585. [PMID: 33324628 PMCID: PMC7726114 DOI: 10.3389/fbioe.2020.617585] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Accepted: 11/02/2020] [Indexed: 12/18/2022] Open
Abstract
Gelatin methacryloyl (GelMA) has been widely used in bone engineering. It can also be filled into the calvarial defects with irregular shape. However, lack of osteoinductive capacity limits its potential as a candidate repair material for calvarial defects. In this study, we developed an injectable magnesium-zinc alloy containing hydrogel complex (Mg-IHC), in which the alloy was fabricated in an atomization process and had small sphere, regular shape, and good fluidity. Mg-IHC can be injected and plastically shaped. After cross-linking, it contents the elastic modulus similar to GelMA, and has inner holes suitable for nutrient transportation. Furthermore, Mg-IHC showed promising biocompatibility according to our evaluations of its cell adhesion, growth status, and proliferating activity. The results of alkaline phosphatase (ALP) activity, ALP staining, alizarin red staining, and real-time polymerase chain reaction (PCR) further indicated that Mg-IHC could significantly promote the osteogenic differentiation of MC3T3-E1 cells and upregulate the genetic expression of collagen I (COL-I), osteocalcin (OCN), and runt-related transcription factor 2 (RUNX2). Finally, after applied to a mouse model of critical-sized calvarial defect, Mg-IHC remarkably enhanced bone formation at the defect site. All of these results suggest that Mg-IHC can promote bone regeneration and can be potentially considered as a candidate for calvarial defect repairing.
Collapse
Affiliation(s)
- Wei-Hua Wang
- Department of Neurosurgery, The Affiliated Suzhou Science and Technology Town Hospital, Nanjing Medical University, Suzhou, China
- Institute of Clinical Medicine Research, The Affiliated Suzhou Science and Technology Town Hospital, Nanjing Medical University, Suzhou, China
| | - Fei Wang
- Institute of Biomaterials and Medical Devices, Southeast University, Suzhou, China
| | - Hai-Feng Zhao
- Department of Pathology, The Affiliated Suzhou Science and Technology Town Hospital, Nanjing Medical University, Suzhou, China
| | - Ke Yan
- Department of Neurosurgery, The Affiliated Suzhou Science and Technology Town Hospital, Nanjing Medical University, Suzhou, China
| | - Cui-Ling Huang
- Department of Neurology, The Second People’s Hospital of Longgang District, Shenzhen, China
| | - Yin Yin
- Laboratory Animal Center, Soochow University, Suzhou, China
| | - Qiang Huang
- Department of Neurosurgery, The Second Affiliated Hospital, Soochow University, Suzhou, China
| | - Zao-Zao Chen
- Institute of Biomaterials and Medical Devices, Southeast University, Suzhou, China
- School of Biological Science and Medical Engineering, Southeast University, Nanjing, China
- *Correspondence: Zao-Zao Chen,
| | - Wen-Yu Zhu
- Department of Neurosurgery, The Affiliated Suzhou Science and Technology Town Hospital, Nanjing Medical University, Suzhou, China
- Institute of Clinical Medicine Research, The Affiliated Suzhou Science and Technology Town Hospital, Nanjing Medical University, Suzhou, China
- Wen-Yu Zhu,
| |
Collapse
|
13
|
Zhao HF, Zhang Y, Zu YL, Li Z, Zhou J, Yu FK, Hu JY, Wei XD, Song YP. [The influence of additive clonal chromosome abnormalities in Ph negative cells on the efficacy of chronic myeloid leukemia]. Zhonghua Nei Ke Za Zhi 2019; 58:803-807. [PMID: 31665854 DOI: 10.3760/cma.j.issn.0578-1426.2019.11.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the influence of additional clonal chromosome abnormalities in Ph negative cells (CCA/Ph(-)) on the efficacy of chronic myeloid leukemia (CML) after tyrosine kinase inhibitors (TKI) treatment. Methods: The clinical data of 28 CML patients with CCA/Ph(-) treated in Henan Cancer Hospital from July 2014 to December 2017 were analyzed retrospectively. The univariate analysis was carried out by Kaplan-Meier method. Multivariate analysis was done by Cox proportional risk model. Results: A total of 28 CCA/Ph(-)patients were recruited including 17 males and 11 females with median age of 42.5 years old. The most common CCA/Ph(-)were trisomy 8 (60.7%), monosomy 7 (14.3%). 64.3% CCA/Ph(-)were transient and 35.7% recurrent (more than 2 times). Cytopenia in two or three lineages of peripheral blood was seen in 42.9% patients. As to the efficacy, 89.3% patients achieved major cytogenetic response (MCyR), 25% with major molecular response (MMR). The median follow-up time was 26.5 months. Treatment failure (TF) of TKI occurred in 32.1% patients with median duration of response 8 (1-41) months. Univariate analysis showed that TF rate was significantly correlated with the frequency of CCA/Ph(-)and cytopenia (all P<0.05). The MMR rate was also significantly correlated with cytopenia (P<0.05). Cytopenia of two lineages or pancytopenia was an independent risk factor related to MMR rate (RR=3.868, 95%CI 1.216-12.298, P=0.022) . Conclusions: Cytopenia in CCA/Ph(-)appears to be an independent risk factor of MMR in CML patients with TKI treatment. The recurrent CCA/Ph(-)may link to higher treatment failure rate. Drug withdrawal or alternative strategy should be considered according to response and the ABL kinase mutations.
Collapse
Affiliation(s)
- H F Zhao
- Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Gui RR, Zu YL, Zhang Y, Han LJ, Zhao HF, Li Z, Yu FK, Wang J, Zhao JJ, Fu YW, Song YP, Zhou J. [Successful treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocytes infusion: three cases report and literatures review]. Zhonghua Xue Ye Xue Za Zhi 2019; 40:333-335. [PMID: 31104448 PMCID: PMC7343007 DOI: 10.3760/cma.j.issn.0253-2727.2019.04.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Download PDF] [Subscribe] [Scholar Register] [Received: 08/22/2018] [Indexed: 11/24/2022]
Affiliation(s)
- R R Gui
- Department of Hematology Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Institute of Hematology, Zhengzhou 450008, China
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Wang X, Xia B, Wang CY, Li MZ, Xu W, Yuan T, Tian C, Zhao HF, Yang HL, Zhao ZG, Wang XF, Wang YF, Yu Y, Zhang YZ. [A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients]. Zhonghua Xue Ye Xue Za Zhi 2019; 40:117-124. [PMID: 30831626 PMCID: PMC7342668 DOI: 10.3760/cma.j.issn.0253-2727.2019.02.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To compare the efficacy of induction chemotherapy with or without autologous hematopoietic stem cell transplantation (auto-HSCT) for newly diagnosed young diffuse large B cell lymphoma (DLBCL) patients. Methods: The retrospective study was performed in 90 cases of young patients (≤60 years) with newly diagnosed DLBCL and an age-adjusted International Prognostic Index (aa-IPI) score of 2 or 3. All of them were treated with R-CHOP (32 cases, rituximab combined with CHOP), dose-intensive regimens (DA-EPOCH, Hyper CVAD/MA or ESHAP) combined with or without rituximab (25 cases), and consolidated with up-front auto-HSCT (33 cases), respectively. The efficacy and the potential predictors were evaluated. Results: ①The median age of 90 patients was 43 (18-60) years old. The median follow-up time was 42 (3-110) months. ②The 5-year progression-free survival (PFS) for R-CHOP group, dose-intensive chemotherapy group and auto-HSCT group were (33.5±10.7) %, (55.3±10.1) % and (65.8±13.6) % (P=0.012), the 5-year overall survival (OS) were (49.7±9.0) %, (61.6±10.2) % and (78.6±7.8) % (P=0.035), respectively. There was no significant difference in 5-years PFS and OS between the R-CHOP group and dose-intensive chemotherapy group (P=0.519, P=0.437) compared with that of the dose-intensive chemotherapy group, auto-HSCT group has higher 5-year PFS (P=0.042). ③ When stratified with IPI score, the high-risk group treated with auto-HSCT (26 cases) showed similar 5-years PFS and 5-years OS to those in the low-risk group with chemotherapy alone (12 cases were in R-CHOP group and 8 cases were in dose-intensive chemotherapy group) [5-years PFS were (62.3 ±14.3)%, (58.3 ±18.6)% and (51.4±18.7)%, respectively, P=0.686; 5-years OS were (69.2±13.9)%, (62.5±15.5)% and (58.3±18.6)%, respectively, P=0.592]. ④However, the high-risk group treated with auto-HSCT (26 cases) showed superior 5-years PFS (P=0.002) and 5-years OS (P=0.019) compared to the high-risk group with chemotherapy alone (20 cases were in R-CHOP group and 17 cases were in dose-intensive chemotherapy group) [5-years PFS were (62.3±14.3)%, (41.1±13.5)% and (21.9±11.6)%, respectively; 5-years OS were (69.2±13.9)%, (51.5%±14.0)% and (35.4±13.6)%, respectively]. ⑤In the univariate analysis, as a whole, patients diagnosed with GCB subtype had higher 3-years PFS (P=0.022) and 3-years OS (P=0.037) compared to non-GCB subtype patients; in subgroup analysis, patients diagnosed with GCB subtype had higher 3-years PFS and 3-years OS compared to non-GCB subtype both in R-CHOP group (P=0.030, P=0.041) and dose-intensive chemotherapy group (P=0.044, P=0.047), but not in auto-HSCT group (P=0.199, P=0.093). ⑥In the multivariate analysis, different molecular classification (GCB/non-GCB) was an independent predictor for PFS and OS both in R-CHOP group [HR=0.274 (95% CI 0.094-0.800), P=0.018; HR=0.408 (95% CI 0.164-1.015), P=0.045] and dose-intensive chemotherapy group [HR=0.423 (95% CI 0.043-1.152), P=0.048; HR=5.758 (95% CI 0.882-6.592), P=0.035]. However, there was no significant difference in PFS and OS for auto-HSCT group between GCB/non-GCB patients. Conclusion: Induction chemotherapy followed by up-front auto-HSCT has significant effect on efficacy for young and untreated patients with high risk DLBCL. Combined with induction chemotherapy followed by up-front auto-HSCT could improve the prognosis of non-GCB patients.
Collapse
Affiliation(s)
- X Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Wang X, Wang CY, Xu W, Yang HL, Zhao HF, Wang XF, Wang YF, Yu Y, Zhang YZ. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2019; 27:52-60. [PMID: 30738447 DOI: 10.7534/j.issn.1009-2137.2019.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To compare the prognostic value of different staging systems in primary intestinal diffuse large B cell lymphoma(PI-DLPCL), and their correlation with clinicopathological characteristics,treatment and prognosis of PI-DLBCL. METHODS A total of 68 patients with PI-DLBCL were recruited from January 2009 to July 2017. All the patients underwent staging by using TNM, Lugano, Blackledge and Musshoff system, survival curves for the PI-DLBCL patients were plotted using the Kaplan-Meier method and were judged by the log-rank test. The accuracy of each staging system for predicting survival of PI-DLBCL patients was evaluated by calculating the area under curve(AUC) of the receiver operating characteristic(ROC). The correlation of the 4 staging systems, clinical features patients and treatment regimes with PFS and OS were analysed. RESULTS The median follow-up time was 52 (1-105) months, the median PFS time was 41(1-86) months, patients did not reached the median OS time. The most frequently involved site was ileocecal (30.9%), followed by small intestine (29.4%) and colon (29.4%), multiple sites involvement (7.4%) and rectum (2.94%).The PFS and OS rates at 5-year were 44.9% and 51.1%, respectively. Kaplan-Meier survival curves and log-rank test results showed that using different staging systems to describe the cumulative retention rates of PFS and OS in PI-DLBCL patients, none of the 4 staging systems can distinguish the survival curves of each stage significantly. The results of ROC curve showed that the prediction ability of the Lugano staging system was better than other staging system for 1 year PFS (AUC=0.826;P=0.015)and 1 year OS(AUC=0-792;P=0.001) in PI-DLBCL patients. The 3 year PFS rate in the operation+chemo or radio-therapy group (62 cases) and the single operation group (6 cases) were 53.9% and 16. 7%,respectively(P=0.116),The 3 year OS rate were 66.7% and 16.7%(P=0.015),respectively. Patients who received chemotherapy combined with rituximab had a higher 3-year PFS(66.0% vs 44.0%,P=0.139) and 3.year OS(70.2% vs.39.2%,P=0.148).The patients with ileocecal lesion had higher PFS rate and OS rate than other sites(P<0.05). Multivariate Cox regression analysis indicated that only bone marrow invasion was an independent prognostic factor in patients with PFS. CONCLUSION Bone marrow invasion is an independent risk factor for PFS in patients with PI-DLBCL , according to this limited preliminary data,Lugano staging system for stratifying and predicting the prognosis of PI-DLBCL patients is better than other staging system.
Collapse
Affiliation(s)
- Xi Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy in Tianjin, Tianjin's Clinical Research Center for Cancer,Tianjin 300060, China
| | - Chao-Yu Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy in Tianjin, Tianjin's Clinical Research Center for Cancer,Tianjin 300060, China
| | - Wen Xu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy in Tianjin, Tianjin's Clinical Research Center for Cancer,Tianjin 300060, China
| | - Hong-Liang Yang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy in Tianjin, Tianjin's Clinical Research Center for Cancer,Tianjin 300060, China
| | - Hai-Feng Zhao
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy in Tianjin, Tianjin's Clinical Research Center for Cancer,Tianjin 300060, China
| | - Xiao-Fang Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy in Tianjin, Tianjin's Clinical Research Center for Cancer,Tianjin 300060, China
| | - Ya-Fei Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy in Tianjin, Tianjin's Clinical Research Center for Cancer,Tianjin 300060, China
| | - Yong Yu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy in Tianjin, Tianjin's Clinical Research Center for Cancer,Tianjin 300060, China
| | - Yi-Zhuo Zhang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy in Tianjin, Tianjin's Clinical Research Center for Cancer,Tianjin 300060, China.E-mail:
| |
Collapse
|
17
|
Xu YJ, Xu W, Chen J, Tian C, Yang HL, Zhao HF, Wang XF, Wang YF, Yu Y, Zhang YZ. [Life Quality and Its Related Factors of Patients with Multiple Myeloma during Maintenance Therapy]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2019; 27:96-103. [PMID: 30738454 DOI: 10.7534/j.issn.1009-2137.2019.01.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To evaluate the quality of life (QOL) on patients with multiple myeloma(MM) during maintenance therapy and to explore the related factors important for QOL. METHODS The demography, clinical and laboratorial data of 66 MM patients during maintenance therapy were collected and explored by using a cross-sectional question naire(EORTC QLQ C30 V 3.0). The statistical analysis was performed using Nowegram normal mode(NM) and reference values(RV) of MM patients which were used as control. RESULTS In comparison with Nowegran normal mode, the scores of general health status, physical function, role function and social function of patients during maintenance therapy were lower than those of normal mode (61.3, 73.9, 65.4 and 65.2 vs 75.3, 89.9, 83.3 and 85.8 respectively), while the scores of constipation and financial difficulty were higher than those of normal mode(16.7 and 44.4 vs 10.7 and 9.7 respectively) (P<0.05). In comparison with reference values, the scores of general health status, emotional and coguitive functions of patients during maintenance therapy were significantly higher than those of reference values(61.3, 81.7 and 84.3 vs 55.7, 71.3 and 78.1 respectively) (P<0.05). In addition, the maintenance therapy yet decreasd the scores of fatigue, nausea and vomiting, pain, dyspnoea, insomnia, appetite loss and constipation of patients, but increased the score of financial difficulty of patients (P<0.05). The age of initial diagnosis, serum LDH level, peripheral neuropathy, high ratio of own expense and underlying diseases were main factors affecting the general health status of patients (P<0.05), while the decrease of Hb level, increase of blood Ca++ level and accompanied genetic changes negatively influence the QOL (P<0.05), while the high culture level showed positive effect on QOL (P<0.05). The choise of drugs for maintenace (therapy thalidomide and bortezomib) not had significant effect on QOL of patients. CONCLUSION The maintenance therapy can improve the QOL of MM patients, the age at initial diagnses, serum LDH level, peripheral neuropathy and high ratio of own expence are the main factors affecting the QOL of MM patients.
Collapse
Affiliation(s)
- Yan-Jie Xu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | - Wen Xu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | - Jing Chen
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | - Chen Tian
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | - Hong-Liang Yang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | - Hai-Feng Zhao
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | - Xiao-Fang Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | - Ya-Fei Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | - Yong Yu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | - Yi-Zhuo Zhang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.E-mail:
| |
Collapse
|
18
|
Abstract
RATIONALE Follicular occlusion triad (FOT) is an autosomal recessive inherited disease and no more than 3 variants of the triad have been reported. We give a report in which scrotal elephantiasis is a variant of FOT and further perform a literature review. PATIENT CONCERNS A 41-year-old man came to us because of a large scrotal cyst and generalized skin lesions that had occurred over the past 10 years. The generalized skin lesions consisted of hidradenitis suppurativa on the perineum and back, acne conglobata in the armpit, and dissecting cellulitis of the scalp. He took antibiotics for a long time but achieved poor effect. Furthermore, he told his father and elder brother also manifested such skin lesions. DIAGNOSES Magnetic resonance showed a mass in the left scrotum with clear boundaries. A routine blood test showed a high leukocyte level of 12 × 10/L and a hemoglobin content of 78 g/L. C-reactive-protein increased. Series of autoimmune antibody tests were negative. The postoperative pathologic findings showed that the mass was an epidermoid cyst, and hematoxylin and eosin staining showed hyperkeratosis of the skin as well as inflammatory and edematous changes. A diagnosis of a variant of FOT was made. INTERVENTIONS We removed skin abscesses and lesioned the inner part with hydrogen peroxide. Then we performed an excision of the scrotal lesion. OUTCOME The patient recovered well and had no evidence of recurrence at a 16-month follow-up. LESSONS We reported a case in which scrotal elephantiasis was a variant of FOT and surgical intervention played an important role in secondary urologic diseases.
Collapse
|
19
|
Zhao HF, Zhang Y, Hu JY, Li Z, Zhou J, Yu FK, Zu YL, Zhou H, Wei XD, Song YP. [Prognosis of clonal chromosomal abnormalities in Philadelphia negative metaphases cells in chronic myeloid leukemia with tyrosine kinase inhibitor therapy]. Zhonghua Xue Ye Xue Za Zhi 2019; 40:209-214. [PMID: 30929388 PMCID: PMC7342545 DOI: 10.3760/cma.j.issn.0253-2727.2019.03.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/09/2018] [Indexed: 12/20/2022]
Abstract
Objective: To investigate the characteristics and prognosis of clonal chromosomal abnormalities appearing in Philadelphia negative metaphases (CCA/Ph(-)) cells in chronic myeloid leukemia (CML) with tyrosine kinase inhibitor (TKI) therapy. Methods: The clinical data of 30 cases with CCA/Ph(-) during TKI treatment in Henan Cancer Hospital from August 2007 to July 2017 were retrospectively analyzed. The univariate factor was analyzed by Kaplan-Meier method. Multiple-factor was analyzed by Cox proportional risk model. Results: Of the 30 cases, 19 (63.3%) were males. At the first detection of CCA/Ph(-) the median age was 44 (rang 14-68) years old and the median treatment of TKI was 13 (rang 2-94) months. The clones proportion of first detected CCA/Ph(-)≥ 50% was found in 18 (60.0%) cases. TKI treatment for 3 months with BCR-ABL(IS) less than 10% was seen in 14 (46.7%) patients. 63.3% (19/30) of CCA/Ph(-) was transient (only one time) and 36.7% (11/30) was repeated (≥2 times) . Trisomy 8 dominant accounted for 60.0% (18/30) , -7/7q- for 13.3% (4/30) , loss of chromosome Y 6.7%. With a median of follow-up 50 months, 76.7% (23/30) cases were in complete cytogenetic response (CCyR) ; 63.3% (19/30) in major molecular response (MMR) , 43.3% (13/30) in undetectable minimal residual disease (UMRD) . The median event-free survival rate of (EFS) were 44 months, and 2-year and 5-year EFS were (82.1±7.3) % and (52.4±12.8) %, respectively. The median overall survival (OS) were 50 months, and 2-year and 5-year OS rates were (92.6±5.0) % and (77.2±14.7) %, respectively. Univariate analysis shows that the 2-year EFS of who in males, more than 2 times CCA/Ph(-), BCR-ABL(IS)>10% at 3 months after TKI were significantly lower than women, transient CCA/Ph(-), and BCR-ABL(IS)≤10% (P<0.05) . The 2-year OS rate in whom the occurrence frequency of CCA/Ph(-) more than twice was significantly lower than those with transient CCA/Ph(-) (P<0.05) . Multivariate analysis showed that CCA/Ph(-) was an independent risk factor (RR=4.741, 95%CI 1.21-18.571, P=0.018) for EFS in CML patients. Conclusion: Trisomy 8, -7/7q-, and -Y were the most common CCA/Ph(-) during TKI treatment, with high clones proportion of ≥50%. CCA/Ph(-) mainly occurred transiently or was permanent occasionally. CCA/Ph(-) recurrence (≥2 times) was an independent risk factor for EFS and OS in CML with TKI.
Collapse
Affiliation(s)
- H F Zhao
- Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Zhou J, Zu YL, Gui RR, Zhang Y, Fu YW, Yu FK, Zhao HF, Li Z, Lin QD, Wang J, Zuo WL, Song YP. [Clinical analysis of six cases with the de novo glomerulitis after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi 2019; 39:757-760. [PMID: 30369188 PMCID: PMC7342261 DOI: 10.3760/cma.j.issn.0253-2727.2018.09.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
目的 探讨异基因造血干细胞移植(allo-HSCT)后肾小球肾炎的发病、诊断及治疗情况。 方法 回顾性分析2008年1月至2016年12月河南省肿瘤医院allo-HSCT后肾小球肾炎患者的临床资料。 结果 478例allo-HSCT患者中6例(1.26%)发生肾小球肾炎,男3例,女3例,中位年龄22(12~36)岁;重型再生障碍性贫血(SAA)2例,急性髓系白血病(AML)4例,移植前均无明确的肾脏病病史,中位发生时间为移植后447(272~1 495)d。4例患者肾功能异常,5例尿潜血阳性,3例高血压,2例高血脂。5例患者曾发生急性GVHD,4例发病时伴有慢性GVHD。肾脏病理:微小病变型肾病1例,膜性肾病4例,系膜增生性肾小球肾炎伴缺血性损伤1例。肾脏免疫组化:IgG阳性4例,IgM阳性1例,C3阳性3例,C1q阳性1例。2例血清抗核抗体阳性,IgG和IgM升高各1例。仅1例患者糖皮质激素治疗有效。5例患者采用低剂量环磷酰胺联合霉酚酸酯治疗,2例完全有效,3例部分有效。4例患者生存良好,2例患者死于肺感染。 结论 allo-HSCT后肾小球肾炎的病理类型以膜性肾病为主,低剂量环磷酰胺联合霉酚酸酯可获得较好疗效。
Collapse
Affiliation(s)
- J Zhou
- Department of Hematology, Affiliated Cancer Hospital Zhengzhou University, Henan Tumor Hospital, Institute of Hematology, Zhengzhou 450003, China
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Wang CY, Xia B, Ning QY, Tian C, Zhao HF, Yang HL, Li MZ, Zhao ZG, Wang XF, Wang YF, Yu Y, Zhang YZ. [Clinical Analysis on the Therapeutic Efficacy of Autologous Hematopoietic Stem Cell Transplantation in 56 Multiple Myeloma Patients]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2019; 26:1396-1402. [PMID: 30295257 DOI: 10.7534/j.issn.1009-2137.2018.05.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To evaluate the therapeutic efficacy and prognosis of autologous stem Hematopoietic cell transplantation (auto-HSCT) in multiple myeloma (MM) patients. METHODS A retrospective study was conducted for 56 patients diagnosed with MM and then received auto-HSCT in our hospital from December 2008 to September 2016. RESULTS All the patients successfully underwent hematopoietic reconstruction without transplantation-related mortality (TRM). The complete response (CR) rate of all the patients after induction chemotherapy was 23.2% (13/56), while the CR rate of these patients with auto-HSCT increased to 78.6% (44/56) (P<0.01). The CR plus VGPR (very good partial response) rates of these 56 patients after induction chemotherapy and auto-HSCT were 53.6%(30/56)and 94.6%(53/56) respectively (P<0.01). The median progression-free survival (PFS) time and median overall survival (OS) time were 37 and 71 months, respectively. The median PFS time in the patients with induction therapy containing bortezomib was 37 months, however, the median OS time did not reach to 71 months; the median PFS (P<0.01) and the median OS (P<0.01) in the patients with the induction chemotherapy without bortezomib was 27 and 51 months, respectively. Univariate analysis demonstrated that the patients maintained CR or VGPR after auto-HSCT or with less than 6 cycles of induction chemotherapy significantly correlated with PFS (P<0.01). CONCLUSION auto-HSCT can further increase the CR rate, prolong PFS and OS time. Sequential auto-HSCT after bortezomib-based therapy is the first line therapy for the transplant-eligible MM patients. Maintenance treatment is beneficial to the sustained CR+VGPR patients after auto-HSCT.
Collapse
Affiliation(s)
- Chao-Yu Wang
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Bing Xia
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Qiao-Yang Ning
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Chen Tian
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Hai-Feng Zhao
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Hong-Liang Yang
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Meng-Zhen Li
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Zhi-Gang Zhao
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Xiao-Fang Wang
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Ya-Fei Wang
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Yong Yu
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China
| | - Yi-Zhuo Zhang
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; Tianjin 300060, China.E-mail:
| |
Collapse
|
22
|
Xu YJ, Xia B, Wang L, Wang CY, Zhao HF, Yang HL, Wang XF, Wang YF, Yu Y, Zhang YZ. [Clinical Analysis of Maintenance Therapy with Thalidomine and Bortezomib for Multiple Myeloma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2019; 26:1668-1674. [PMID: 30501702 DOI: 10.7534/j.issn.1009-2137.2018.06.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To evaluate the therapeutic effect and adverse reactions of the maintenance therapies with Thalidomine or Bortezomib in the patients with newly diagnosed multiple myeloma (MM), so as to provide a reference for clinical treatment. METHODS A retrospective analysis was conducted to compare the progression-free survival (PFS), overall survival (OS) and adverse reaction rate of 23 MM patients received the maintenance therapies of Bortezomib and of 68 MM patients received maintenance therapy of Thalidomine. RESULTS The maintenance therapy with Bortezomib could extend the PFS of MM patients as compared with Thalidomine (PFS rate of patients on the maintenance therapy of Bortezomib in 12th, and 24th month was 100%, 88.89%, and that of Thalidomine-treated group was 72.31%, 47.54%). What's more, some specific patients could get better 2-year PFS rate in Bortezomib group than that in Thalidomine group, such as older than 65 years old, after autologous hematopoietic stem cell transplantation(ASCT), having genetic changes, extramedullary lesions, poor renal function, low serum free light chain ratio, high β2-MG, anemia, high LDH, VGPR of induction and consolidation therapy. The OS rate of Bortezomib on 18th, 24th and 30th month was 100%, 88.89%, 80% verus 91.52%,83.63%,72.90% of the group with thalidemide at the same time. As for 2-year OS rate, the Bortezomib group was higher than Thalidomine without statistical differences. However, the patients such as older than 65 years old, poor renal function and with extramedullary lesions, would also get higher 2-year OS rate from Bortezomi. Bortezomib and thalidomide could cause bone marrow suppression, peripheral neuritis and other adverse reactions. CONCLUSION The efficacy of maintenance therapy with Bortezomib is superior to thalidomide. As a conclusion, bortezomib is a better option for maintenance therapy of MM patient.
Collapse
Affiliation(s)
- Yan-Jie Xu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing Municipal Key Laboratory of Cancer Prevention and Therapy, Tianjin Municipal Clinical Research Center for Cancer,Tianjin 300060, China
| | - Bing Xia
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing Municipal Key Laboratory of Cancer Prevention and Therapy, Tianjin Municipal Clinical Research Center for Cancer,Tianjin 300060, China
| | - Lu Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing Municipal Key Laboratory of Cancer Prevention and Therapy, Tianjin Municipal Clinical Research Center for Cancer,Tianjin 300060, China
| | - Chao-Yu Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing Municipal Key Laboratory of Cancer Prevention and Therapy, Tianjin Municipal Clinical Research Center for Cancer,Tianjin 300060, China
| | - Hai-Feng Zhao
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing Municipal Key Laboratory of Cancer Prevention and Therapy, Tianjin Municipal Clinical Research Center for Cancer,Tianjin 300060, China
| | - Hong-Liang Yang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing Municipal Key Laboratory of Cancer Prevention and Therapy, Tianjin Municipal Clinical Research Center for Cancer,Tianjin 300060, China
| | - Xiao-Fang Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing Municipal Key Laboratory of Cancer Prevention and Therapy, Tianjin Municipal Clinical Research Center for Cancer,Tianjin 300060, China
| | - Ya-Fei Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing Municipal Key Laboratory of Cancer Prevention and Therapy, Tianjin Municipal Clinical Research Center for Cancer,Tianjin 300060, China
| | - Yong Yu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing Municipal Key Laboratory of Cancer Prevention and Therapy, Tianjin Municipal Clinical Research Center for Cancer,Tianjin 300060, China
| | - Yi-Zhuo Zhang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjing Municipal Key Laboratory of Cancer Prevention and Therapy, Tianjin Municipal Clinical Research Center for Cancer,Tianjin 300060, China.E-mail:
| |
Collapse
|
23
|
Wu L, Zhang YZ, Xia B, Li XW, Yuan T, Tian C, Zhao HF, Yu Y, Sotomayor E. [Ibrutinib inhibits mesenchymal stem cells-mediated drug resistance in diffuse large B-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2019; 38:1036-1042. [PMID: 29365396 PMCID: PMC7342183 DOI: 10.3760/cma.j.issn.0253-2727.2017.12.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
目的 探讨依布替尼克服弥漫大B细胞淋巴瘤(DLBCL)细胞耐药的机制。 方法 ①体外实验:以DLBCL细胞系SUDHL10细胞(GCB亚型)、HBL-1(ABC亚型)以及8例DLBCL患者原代细胞为研究对象,与正常人骨髓基质细胞(MSC)共培养后,显微镜下计数向MSC趋化迁移及与MSC黏附的DLBCL细胞数,ELISA法检测MSC的CXCL12表达水平,流式细胞术检测DLBCL细胞的CXCR4表达水平;以携带有CXCR4的慢病毒转染HBL-1细胞,米托蒽醌、依布替尼处理后与MSC共培养,流式细胞术检测细胞凋亡水平;倒置显微镜下观察HBL-1细胞集落形成情况。②体内实验:以HBL-1细胞构建的NOD/SCID肿瘤模型小鼠为研究对象,观察依布替尼治疗后肿瘤体积变化。 结果 ①依布替尼处理后,DLBCL细胞向MSC的迁移数和与MSC的黏附比例明显降低(P值均<0.05),并呈剂量依赖性。②与依布替尼处理前比较,处理后MSC的CXCL12表达水平降低(SUDHL10细胞:660 pg/ml对1 400 pg/ml,P=0.004;HBL-1细胞:720 pg/ml对1 490 pg/ml,P=0.018;DLBCL原代细胞:850 pg/ml对1 450 pg/ml,P=0.004),DLBCL细胞的CXCR4表达水平降低(P值均<0.05)。③共培养时,对照组、米托蒽醌组、依布替尼组、米托蒽醌组+依布替尼组的HBL-1细胞凋亡比例分别为15.1%、17.5%、23.5%、58.7%,转染过表达CXCR4后,HBL-1细胞凋亡比例分别为14.2%、16.1%、22.5%、38.3%,共培养联合用药组HBL-1细胞凋亡比例高于单药培养组,差异均有统计学意义(P值均<0.05)。④对照组、MSC组、依布替尼组、MSC组+依布替尼组集落数分别为113±5、205±4、62±9、123±3(每孔2.5×103),模型小鼠皮下肿瘤体积分别为6 500、17 000、4 000、10 000 mm3,依布替尼处理后较处理前集落数和肿瘤体积明显减少,差异均有统计学意义(P值均<0.05)。 结论 依布替尼靶向作用于CXCL12/CXCR4轴,抑制CXCR4表达从而克服MSC介导的耐药作用,并且能够在体内外抑制MSC促淋巴瘤细胞集落形成的作用。为依布替尼治疗复发耐药DLBCL提供了理论依据。
Collapse
Affiliation(s)
- L Wu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center For Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | - Y Z Zhang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center For Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Zhao HF, Zhang Y, Li Z, Zhou J, Zu YL, Yu FK, Gui RR, Wei XD, Song YP. [Effect of stopping tyrosine kinase inhibitors during pregnancy on disease status and reproductive outcomes among patients with chronic myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi 2018; 39:540-545. [PMID: 30122011 PMCID: PMC7342204 DOI: 10.3760/cma.j.issn.0253-2727.2018.07.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Indexed: 11/05/2022]
Abstract
Objective: To explore the pregnancy outcome and disease status among patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitor (TKI) when they stopped TKI treatment during pregnancy. Methods: The clinical characteristics, reproductive outcomes and disease status of the patients who stopped TKI due to pregnancy between November 2004 to November 2017 were retrospectively collected. Results: A total of 14 CML patients in chronic phase (CML-CP), 12 patients were Sokal-low-risk. The median time of TKI treatment was 46.5 (15-123) months before the drug was stopped. The median age at the time of pregnancy was 29 (24-32) years. The median time of TKI exposure was 4 (0-9) weeks in 12 accidental pregnancies. Outcomes were available for 13 pregnancies, 9 cases (69.2%) delivered healthy babies, 1 case (7.7%) delivered polydactylia malformation baby, 3 cases (23.1%) had spontaneous abortion. The last one was still in pregnancy (no organ malformations were observed in color Doppler ultrasound). At the end of the follow up date, 10 children developed normal, the median age was 14 (0.7-65) months. Of the 14 patients who stopped TKI, 7 in complete molecular response (CMR), 3 in MR(4) (BCR-ABL(IS) <0.01%, ABL transcript >10 000), 2 in major molecular response (MMR), 2 in complete cytogenetic response (CCyR). The median time of TKI discontinuation during pregnancy was 33.5 (4-40) weeks. At the end of pregnancy, 4 cases were in CMR, 4 in MR(4), 1 in MMR and 4 in CCyR. No patients lost CCyR and complete hematologic remission. Conclusions: During the treatment of imatinib and Nilotinib, unplanned pregnancy may have a normal infant, but may lead to spontaneous abortion and congenital malformations. Female of CML-CP who had sustained and stable MMR at least 24 months and Sokal-low-risk had higher safety factor discontinued TKI during pregnancy, but still had a risk of increasing tumor load, so monitored the level of BCR-ABL of peripheral blood monthly during pregnancy is necessary.
Collapse
Affiliation(s)
- H F Zhao
- Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Zhao HF, Sun JH, Liu S, Liu Y, Liu GF. [Effect of Shuxuetong injection on anticoagulant effect of warfarin in rats]. Zhongguo Zhong Yao Za Zhi 2018; 42:982-988. [PMID: 28994544 DOI: 10.19540/j.cnki.cjcmm.20170121.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 10/31/2016] [Indexed: 11/18/2022]
Abstract
To explore the effect of Shuxuetong injection on the pharmacodynamics and pharmacokinetics of warfarin in rats, and to provide reference for rational drug use. In studies on the single dose of warfarin, Wistar rats were randomly divided into four groups: blank control group(group A), Shuxuetong injection group(group B), warfarin control group(group C), and warfarin+Shuxuetong injection group(group D). In studies on the steady state of warfarin, Wistar rats were randomly divided into warfarin control group(group E) and warfarin+Shuxuetong injection group(group F). To investigate the pharmacodynamic effect of Shuxuetong injection on warfarin, prothrombin time(PT) and activated partial thromboplastin time(APTT) were measured by coagulation analyzer, and international normalized ratio(INR) was calculated. To investigate the pharmacokinetic effect of Shuxuetong injection on warfarin, the blood concentrations of S-warfarin and R-warfarin were determined by UPLC-MS/MS combined with technology of chiral chromatographic column, and the related pharmacokinetic parameters were calculated accordingly. The results on the single dose of warfarin showed that Shuxuetong injection markedly increased PT, INR(P<0.01), and APTT(P<0.05). Meanwhile, when Shuxuetong injection was co-administrated with warfarin, it significantly increased PT, INR(P<0.01), and APTT(P<0.05) as compared with warfarin control group. In addition, increased pharmacokinetic parameters including Cmax, AUC0-t and AUC0-∞, prolonged t1/2, and decreased CL/F were observed for S-warfarin and R-warfarin. The results of the steady state of warfarin suggested that Shuxuetong injection significantly increased PT and INR of warfarin(P<0.01), and elevated the plasma concentrations of S-warfarin and R-warfarin when co-administrated with warfarin. These findings indicated that Shuxuetong injection had anticoagulant effect, and would produce pharmacodynamics synergistic action when it was co-administrated with warfarin. Shuxuetong injection also decelerated the metabolism of warfarin, and resulted in pharmacokinetics interaction. Therefore, Shuxuetong injection could significantly increase anticoagulant effect of warfarin, indicating that the combination use of these two drugs should be refrained in order to avoid the risk of bleeding in clinical application. If they need to be used in combination, special attention should be paid to ensure the safety of patients.
Collapse
Affiliation(s)
- Hai-Feng Zhao
- Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Key Laboratory of University in Heilongjiang Province, Harbin 150086, China
| | - Jia-Hui Sun
- Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Key Laboratory of University in Heilongjiang Province, Harbin 150086, China
| | - Shuang Liu
- Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Key Laboratory of University in Heilongjiang Province, Harbin 150086, China
| | - Yan Liu
- Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Key Laboratory of University in Heilongjiang Province, Harbin 150086, China
| | - Gao-Feng Liu
- Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Key Laboratory of University in Heilongjiang Province, Harbin 150086, China
| |
Collapse
|
26
|
Liu J, Zhou Q, Wu CP, Xu YW, Liu WL, Zhao HF, Li WP. SPHK2 protein expression, Ki-67 index and infiltration of tumor-associated macrophages (TAMs) in human glioma. Histol Histopathol 2018; 33:987-994. [PMID: 29697136 DOI: 10.14670/hh-11-995] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
INTRODUCTION Sphingosine kinases (SPHKs), the Ki-67 index and tumor-associated macrophages (TAMs) are associated with diverse human malignancies, including glioma. SPHK2, a subtype of SPHKs, has not been assessed in glioma or correlated with the Ki-67 index or TAM infiltration. We tested the hypothesis that expression of SPHK2 correlates with the Ki-67 index and TAM infiltration in patients with glioma. MATERIALS AND METHOD Western blot analysis was performed on protein lysates prepared from human astrocyte (HA) and glioma cell lines. Immunofluorescence was used to determine the subcellular location of SPHK2 protein in glioma cells. Next, immunohistochemistry was employed to analyze the correlations among SPHK2, Ki-67, CD68, and CD206 in 11 non-neoplastic brain tissues and 60 glioma tissues. All slides were evaluated under ×400 magnification, and the ratio of positively stained cells to the total number of cells was calculated for analysis. RESULTS SPHK2, CD68 and CD206 were all increased in glioma tissues compared to non-neoplastic brain tissues, but there were no differences between WHO grades of glioma. Ki-67 was highest in WHO grade IV tumors and lowest in non-neoplastic brain tissues, and all between-group differences were statistically significant. Moreover, SPHK2 expression was positively correlated with the Ki-67, CD68 and CD206 indexes. Finally, the CD68 and CD206 indexes were both associated with the Ki-67 index. CONCLUSION SPHK2 protein expression, the Ki-67 index and TAM infiltration in human glioma tissue were reported in this study for the first time. SPHK2 was positively associated with TAM infiltration and glioma proliferation. Mechanistically, SPHK2 may promote glioma growth by stimulating TAMs to polarize M2-type macrophages.
Collapse
Affiliation(s)
- J Liu
- Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.,Department of Neurosurgery and Shenzhen Key Laboratory of Neurosurgery, Shenzhen University 1st Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen, China
| | - Q Zhou
- Department of Neurosurgery and Shenzhen Key Laboratory of Neurosurgery, Shenzhen University 1st Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen, China.,Department of Neurosurgery, Shenzhen Second People's Hospital, Clinical Medicine College of Anhui Medical University, Shenzhen, China
| | - C P Wu
- Department of Neurosurgery and Shenzhen Key Laboratory of Neurosurgery, Shenzhen University 1st Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen, China.,Department of Neurosurgery, Shenzhen Second People's Hospital, Clinical Medicine College of Anhui Medical University, Shenzhen, China
| | - Y W Xu
- Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.,Department of Neurosurgery and Shenzhen Key Laboratory of Neurosurgery, Shenzhen University 1st Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen, China
| | - W L Liu
- Department of Neurosurgery and Shenzhen Key Laboratory of Neurosurgery, Shenzhen University 1st Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen, China
| | - H F Zhao
- Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.,Department of Neurosurgery and Shenzhen Key Laboratory of Neurosurgery, Shenzhen University 1st Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen, China
| | - W P Li
- Department of Neurosurgery and Shenzhen Key Laboratory of Neurosurgery, Shenzhen University 1st Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen, China.,Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
| |
Collapse
|
27
|
Zhao JJ, Zhang YL, Zhang SJ, Zhou J, Yu FK, Zu YL, Zhao HF, Li Z, Song YP. [The molecular-cytogenetic characterization and tyrosine kinase inhibitors efficacy in newly diagnosed chronic phase CML patients with variant Philadelphia chromosomes]. Zhonghua Xue Ye Xue Za Zhi 2018; 39:212-218. [PMID: 29562466 PMCID: PMC7343003 DOI: 10.3760/cma.j.issn.0253-2727.2018.03.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/21/2017] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the molecular-cytogenetic characterization and impact on tyrosine kinase inhibitors (TKIs) therapy in chronic phase of chronic myeloid leukemia (CML-CP) patients with variant Ph chromosome (vPh). Methods: The clinical data of 32 patients with vPh chromosomes were collected and compared with 703 patients with typical Ph chromosome in newly diagnosed CML-CP who were on first-line imatinib (IM) and with BCR-ABL transcript of P210. Results: There was no significant difference in demographic and hematological characteristics between vPh and classic Ph patients. 3(9.4%) of the 32 vPh cases were simple variant translocations. Among the remaining 29 cases with complex variant translocations, 28 cases (87.5%) involved 3 chromosomes, and only 1 (3.1%) involved 4 chromosomes. Except for 8, 15, 18, X, and Y chromosomes, the other chromosomes were involved. The frequency of chromosome 12q(15.5%) and 1p (12.1%) were higher involved. The most common FISH signal pattern was 2G2R1Y (74.1%), followed by 1G1R2F (14.8%), 2G1R1Y (3.7%), 1G2R1Y (3.7%), 1G1R1Y (3.7%). The comparison of complete cytogenetic response (CCyR) (P=0.269), major molecular response (MMR) (P=0.391) were carried out between simple and complex mechanisms, without difference. Compared with the classic Ph, the patients with vPh had higher IM primary resistance rate (χ2=3.978, P=0.046), especially primary hematological resistance (χ2=7.870, P=0.005), but the difference of CCyR (χ2=0.192, P=0.661), MMR (χ2=0.822, P=0.365), EFS (χ2=0.509, P=0.476), OS (χ2=3.485, P=0.062) were not statistically significant, and multivariate analysis showed that the presence of vPh did not affect OS (RR=0.692, 95%CI 0.393-1.765, P=0.658)、EFS (RR=0.893, 95%CI 0.347-2.132, P=0.126) and PFS (RR=1.176, 95%CI 0.643-2.682, P=0.703). Conclusion: CML-CP patients with vPh and classic Ph had similar demographic and hematological characteristics. Except for 22q11, 9q34, the frequency of chromosome 12q and 1p were higher involved. The most common FISH signal pattern was 2G2R1Y, and different mechanisms had no impact on TKIs therapy. Compared with cases with classic Ph chromosomes, the patients with vPh chromosomes had higher risk of IM primary resistance, especially primary hematological resistance, which can obtain deeper molecular response quickly after changing to second-generation TKIs and didn't affect long-term outcomes and OS.
Collapse
Affiliation(s)
- J J Zhao
- Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China
| | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Abstract
In the sign language fingerspelling scheme, letters in the alphabet are presented by a distinctive finger shape or movement. The presented work is conducted for autokinetic translating fingerspelling signs to text. A recognition framework by using intensity and depth information is proposed and compared with some distinguished works. Histogram of Oriented Gradients (HOG) and Zernike moments are used as discriminative features due to their simplicity and good performance. A Deep Belief Network (DBN) composed of three Restricted Boltzmann Machines (RBMs) is used as a classifier. Experiments are executed on a challenging database, which consists of 120,000 pictures representing 24 alphabet letters over five different users. The proposed approach obtained higher average accuracy, outperforming all other methods. This indicates the effectiveness and the abilities of the proposed framework.
Collapse
Affiliation(s)
- Yong Hu
- The Laboratory for Internet of Things and Mobile Internet, Technology of Jiangsu Province, Huaiyin Institute of Technology, P. R. China
- School of Software Engineering, Jinling Institute of Technology, Nanjing, P. R. China
| | - Hai-Feng Zhao
- School of Software Engineering, Jinling Institute of Technology, Nanjing, P. R. China
| | - Zhi-Gang Wang
- School of Software Engineering, Jinling Institute of Technology, Nanjing, P. R. China
| |
Collapse
|
29
|
Wang TT, Li SX, Xia B, Zhao HF, Xu W, Yang HL, Wang XF, Yu Y, Sun BC, Zhang YZ. [Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma]. Zhonghua Yi Xue Za Zhi 2017; 97:1400-1405. [PMID: 28535626 DOI: 10.3760/cma.j.issn.0376-2491.2017.18.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To observe the expression of three microenvironment related prognostic factors, i. e. programmed death 1 (PD-1), forkhead box protein 3(FOXP3) and colony-stimulating factor 1 receptor(CSF-1R) protein in classical Hodgkin's lymphoma (CHL) patients, and to explore the correlation between the protein expression and the prognosis of the patients. Methods: A total of 45 cases of CHL patients, who had been admitted to the Tianjin Medical University Cancer Institute and Hospital and Chinese PLA General Hospital from February 2005 to August 2010 were analyzed, including clinical features, prognostic factors, and treatment regimens. CHL patients' specimens were collected and the expression of PD-1, FOXP3, and CSF-1R proteins analyzed by immunohistochemical staining. Epstein-Barr virus encoded mRNA (EBER) was detected by in situ hybridization analysis. The relationship between the protein expression of PD-1, FOXP3 and CSF-1R and the patients' outcome was analyzed with clinical and follow-up data. Survival analysis was performed by Kaplan-Meier method, the Cox proportional hazard model was used to perform multivariate analysis. Results: In this cohort of 45 CHL patients, PD-1 positive was found in 7 cases (15.6%), FOXP3 high expression in 23 cases (51.1%), CSF-1R positive in 18 cases (40.0%). In the univariate analysis, the expression of FOXP3 and CSF-1R, International Prognostic Index (IPI) score, Ann Arbor stage and EBER were related with the patients' 5-year overall survival (OS); IPI score, the expression of FOXP3 and EBER were related with the patients' 5-year progress-free survival (PFS). Multivariate analysis indicated that CSF-1R protein expression was the independent prognostic factor affecting the patients' 5-year OS(HR: 8.918, P=0.020), and FOXP3 protein expression was the independent prognostic factor affecting the patients' 5-year PFS (HR: 0.122, P<0.001). And EBV was an independent prognostic factor of PFS and OS in the CHL patients. Conclusion: Microenvironment related prognostic factors FOXP3, CSF-1R and EBV may be independent prognostic factors of CHL and this study may provide novel strategies for targeted therapy of CHL.
Collapse
Affiliation(s)
- T T Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Wang L, Yan B, Yu Y, Wang YF, Yang HL, Zhao HF, Wang XF, Wu XX, DA WM, Li SX, Zhang YZ. [Effect of Rigorous Staging at the First Diagnosis on Prognosis of Patients with Follicular Lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2017; 25:126-132. [PMID: 28245388 DOI: 10.7534/j.issn.1009-2137.2017.01.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
BACKGROUND A survey of early stage follicular lymphoma(FL) revealed that the rigorously staged FL patients at first diagnosis had a better outcome as compared with non-rigorous staged FL patients, but there were no similar reports in China. OBJECTIVE To explore the relationship between the rigorous staging at first diagnosis and the prognosis of FL patients at different stages. METHODS The clinical data of 111 patients with newly diagnosed FL from 2008 to 2014 year were collected and analyzed. The rigorous staging included: (1) bone marrow aspiration and biopsy, (2) imaging examination of whole body including CT and ultrasounic scan, or PET/CT, either or both is defined as rigorous staging, or else as non-rigorous staging. RESULTS The FL patients at I-II stages by rigorous staging showed a superior progression-free survival(PFS) compared with non-rigorous staging patients(P=0.048). For all the patients, the age, serum LDH, bone marrow lesion and more than 3 foci of diameter larger than 3 cm correlated with prognosis in univariate analysis, and multivariate analysis revealed that the age, serum LDH and bone marrow imolvement were the independent prognostic factors. CONCLUSION Rigorous staging leads to better outcomes, suggesting that accurate and appropriate testing is important for the patients at the first treatment. The close correlation of bone marrow with prognosis indicates that the evaluation of bone marrow is very important for the daily clinical practice.
Collapse
Affiliation(s)
- Lu Wang
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - Bei Yan
- Department of Hematology, The First Affiliated Hospital of Chinese PLA General Hospital, Beijing 100048, China
| | - Yong Yu
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - Ya-Fei Wang
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - Hong-Liang Yang
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - Hai-Feng Zhao
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - Xiao-Fang Wang
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - Xiao-Xiong Wu
- Department of Hematology, The First Affiliated Hospital of Chinese PLA General Hospital, Beijing 100048, China
| | - Wan-Ming DA
- Department of Hematology, The Chinese PLA General Hospital, Beijing 100853, China
| | - Su-Xia Li
- Department of Hematology, The Chinese PLA General Hospital, Beijing 100853, China
| | - Yi-Zhuo Zhang
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China. E-mail:
| |
Collapse
|
31
|
Li ZJ, Zhan F, Xiao H, Zhang X, Kong QY, Fan XB, Liu WQ, Huang MY, Huang C, Gao YJ, Li XB, Meng QY, Feng K, Chen B, Tung CH, Zhao HF, Tao Y, Wu LZ. Tracking Co(I) Intermediate in Operando in Photocatalytic Hydrogen Evolution by X-ray Transient Absorption Spectroscopy and DFT Calculation. J Phys Chem Lett 2016; 7:5253-5258. [PMID: 27973864 DOI: 10.1021/acs.jpclett.6b02479] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
X-ray transient absorption spectroscopy (XTA) and optical transient spectroscopy (OTA) were used to probe the Co(I) intermediate generated in situ from an aqueous photocatalytic hydrogen evolution system, with [RuII(bpy)3]Cl2·6H2O as the photosensitizer, ascorbic acid/ascorbate as the electron donor, and the Co-polypyridyl complex ([CoII(DPA-Bpy)Cl]Cl) as the precatalyst. Upon exposure to light, the XTA measured at Co K-edge visualizes the grow and decay of the Co(I) intermediate, and reveals its Co-N bond contraction of 0.09 ± 0.03 Å. Density functional theory (DFT) calculations support the bond contraction and illustrate that the metal-to-ligand π back-bonding greatly stabilizes the penta-coordinated Co(I) intermediate, which provides easy photon access. To the best of our knowledge, this is the first example of capturing the penta-coordinated Co(I) intermediate in operando with bond contraction by XTA, thereby providing new insights for fundamental understanding of structure-function relationship of cobalt-based molecular catalysts.
Collapse
Affiliation(s)
- Zhi-Jun Li
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Fei Zhan
- Beijing Synchrotron Radiation Facility, Institute of High Energy Physics, Chinese Academy of Sciences , Beijing 100049, People's Republic of China
| | - Hongyan Xiao
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Xiaoyi Zhang
- X-ray Sciences Division, Advanced Photon Source, Argonne National Laboratory , Argonne, Illinois 60430, United States
| | - Qing-Yu Kong
- Synchrotron SOLEIL, L'Orme des Merisiers , Saint Aubin 91192 GIF-sur-Yvette Cedex, France
| | - Xiang-Bing Fan
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Wen-Qiang Liu
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Mao-Yong Huang
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Cheng Huang
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Yu-Ji Gao
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Xu-Bing Li
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Qing-Yuan Meng
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Ke Feng
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Bin Chen
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Chen-Ho Tung
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| | - Hai-Feng Zhao
- Beijing Synchrotron Radiation Facility, Institute of High Energy Physics, Chinese Academy of Sciences , Beijing 100049, People's Republic of China
| | - Ye Tao
- Beijing Synchrotron Radiation Facility, Institute of High Energy Physics, Chinese Academy of Sciences , Beijing 100049, People's Republic of China
| | - Li-Zhu Wu
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, The Chinese Academy of Sciences , Beijing 100190, People's Republic of China
| |
Collapse
|
32
|
Zu YL, Zhang YL, Zhou J, Zhao HF, Gui RR, Li Z, Gao SK, Song YP. [The efficacy analysis of interferon combined with imatinib in chronic myelogenous leukemia patients with ABL kinase domain mutations]. Zhonghua Nei Ke Za Zhi 2016; 55:794-796. [PMID: 27686442 DOI: 10.3760/cma.j.issn.0578-1426.2016.10.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
To retrospectively analyze the efficacy of interferon plus imatinib (IM) in patients with chronic-phase chronic myelogenous leukemia(CML-CP)and ABL kinase domain mutations. The mutation rates of ABL kinase region in patients with Sokal score low, medium and high risk CML-CP were statistically significant (6.25%, 9.42% and 47.06%, P<0.05). The response rates of interferon plus IM versus second-generation TKI in CML-CP with non-T315I ABL kinase domain mutations were comparable (61.11% vs 65.52%, P>0.05). When CML-CP patients with ABL kinase domain mutations were resistant to TKI or not accessible to second-generation TKI, interferon plus IM can be an alternative choice.
Collapse
Affiliation(s)
- Y L Zu
- Department of Hematology, Henan Tumor Hospital, Affiliated Tumor Hospital of Zhengzhou University, Henan Institute of Hematology, Zhengzhou 450008, China
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Xiao ZY, Yao B, Li YF, Ding ZH, Gao ZM, Zhao HF, Zhang LG, Zhang ZZ, Sui YR, Wang G. Influencing Mechanism of the Selenization Temperature and Time on the Power Conversion Efficiency of Cu2ZnSn(S,Se)4-Based Solar Cells. ACS Appl Mater Interfaces 2016; 8:17334-17342. [PMID: 27323648 DOI: 10.1021/acsami.6b05201] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Cu2ZnSn(S,Se)4 (CZTSSe) films were deposited on the Mo-coated glass substrates, and the CZTSSe-based solar cells were successfully fabricated by a facile solution method and postselenization technique. The influencing mechanisms of the selenization temperature and time on the power conversion efficiency (PCE), short-circuit current density (Jsc), open-circuit voltage (Voc), and fill factor (FF) of the solar cell are systematically investigated by studying the change of the shunt conductance (Gsh), series resistance (Rs), diode ideal factor (n), and reversion saturation current density (J0) with structure and crystal quality of the CZTSSe film and CZTSSe/Mo interface selenized at various temperatures and times. It is found that a Mo(S1-x,Sex)2 (MSSe) layer with hexagonal structure exists at the CZTSSe/Mo interface at the temperature of 500 °C, and its thickness increases with increasing selenization temperature and time. The MSSe has a smaller effect on the Rs, but it has a larger influence on the Gsh, n, and J0. The PCE, Voc, and FF change dominantly with Gsh, n, and J0, while Jsc changes with Rs and Gsh, but not Rs. These results suggest that the effect of the selenization temperature and time on the PCE is dominantly contributed to the change of the CZTSSe/CdS p-n junction and CZTSSe/MSSe interface induced by variation of the quality of the CZTSSe film and thickness of MSSe in the selenization process. By optimizing the selenization temperature and time, the highest PCE of 7.48% is obtained.
Collapse
Affiliation(s)
- Zhen-Yu Xiao
- Key Laboratory of Physics and Technology for Advanced Batteries (Ministry of Education), College of Physics, Jilin University , Changchun 130012, China
- State Key Lab of Superhard Materials, College of Physics, Jilin University , Changchun 130012, China
| | - Bin Yao
- Key Laboratory of Physics and Technology for Advanced Batteries (Ministry of Education), College of Physics, Jilin University , Changchun 130012, China
- State Key Lab of Superhard Materials, College of Physics, Jilin University , Changchun 130012, China
| | - Yong-Feng Li
- Key Laboratory of Physics and Technology for Advanced Batteries (Ministry of Education), College of Physics, Jilin University , Changchun 130012, China
- State Key Lab of Superhard Materials, College of Physics, Jilin University , Changchun 130012, China
| | - Zhan-Hui Ding
- Key Laboratory of Physics and Technology for Advanced Batteries (Ministry of Education), College of Physics, Jilin University , Changchun 130012, China
- State Key Lab of Superhard Materials, College of Physics, Jilin University , Changchun 130012, China
| | - Zhong-Min Gao
- State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University , 2699 Qianjin Street, Changchun 130012, China
| | - Hai-Feng Zhao
- State Key Laboratory of Luminescence and Applications, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences , No. 3888 Dongnanhu Road, Changchun 130033, China
| | - Li-Gong Zhang
- State Key Laboratory of Luminescence and Applications, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences , No. 3888 Dongnanhu Road, Changchun 130033, China
| | - Zhen-Zhong Zhang
- State Key Laboratory of Luminescence and Applications, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences , No. 3888 Dongnanhu Road, Changchun 130033, China
| | - Ying-Rui Sui
- Key Laboratory of Functional Materials Physics and Chemistry of the Ministry of Education, Jilin Normal University , Siping 136000, China
| | - Gang Wang
- State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences , 5625 Renmin Street, Changchun130022, China
| |
Collapse
|
34
|
Wang TT, Zhang ZG, Yang HL, Li Q, Xia B, Zhao HF, Yu Y, Wang XF, Wang YF, Zhang YZ. [Analysis of Clinical Characteristics and Prognosis of 46 Elderly Patients with Peripheral T Cell Lymphoma (PTCL)]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2016; 24:438-43. [PMID: 27151006 DOI: 10.7534/j.issn.1009-2137.2016.02.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To investigate the clinical characteristics and prognostic factors of patients with peripheral T cell lymphoma (PTCL). METHODS The clinical data of 46 elderly PTCL patients admitted in Tianjin Medical University Cancer Hospital from April 2008 to August 2014 were collected, the clinical features, prognostic factors and treatments, as well as followed-up outcome were analyzed retrospectively. Survival analysis was performed by Kaplan-Meier method, and the COX proportional hazard model was used to perform multivariate analysis. RESULTS The median survival time was 11 months, and the expected 1-year, 2-year and 3-year overall survival rate (OS) was 50%, 36% and 33%, respectively. Univariate analysis showed that the age, ECOG score, Charlson Comorbidity Index Score, the efficacy and course of chemotherapy were all the prognostic indicators affecting the OS and progression free survival (PFS) in this cohort of elderly patients. Multivariate analysis indicated that ECOG score and course of chemotherapy were the independent prognostic indicators affecting the OS and PFS (P < 0.05). CONCLUSION ECOG score and course of chemotherapy are of great significance for predicting the prognosis in elderly PTCL patients. The elderly patients's general condition and completion of a certain intensity of chemotherapy are an important measure to prolong survival time in elderly PTCL patients.
Collapse
Affiliation(s)
- Teng-Teng Wang
- Tianjin Medical University Cancer Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thearpy, Tianjin 300060, China
| | - Zhi-Gang Zhang
- Tianjin Medical University Cancer Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thearpy, Tianjin 300060, China
| | - Hong-Liang Yang
- Tianjin Medical University Cancer Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thearpy, Tianjin 300060, China
| | - Qian Li
- Tianjin Medical University Cancer Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thearpy, Tianjin 300060, China
| | - Bing Xia
- Tianjin Medical University Cancer Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thearpy, Tianjin 300060, China
| | - Hai-Feng Zhao
- Tianjin Medical University Cancer Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thearpy, Tianjin 300060, China
| | - Yong Yu
- Tianjin Medical University Cancer Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thearpy, Tianjin 300060, China
| | - Xiao-Fang Wang
- Tianjin Medical University Cancer Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thearpy, Tianjin 300060, China
| | - Ya-Fei Wang
- Tianjin Medical University Cancer Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thearpy, Tianjin 300060, China
| | - Yi-Zhuo Zhang
- Tianjin Medical University Cancer Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thearpy, Tianjin 300060, China. E-mail:
| |
Collapse
|
35
|
Abstract
Over many years, parts of Panax ginseng (root and rhizome) have been identified and applied for medical purposes as traditional Chinese herbal medicine. Recently, research has indicated that ginseng fruit also contains similar compounds and is as rich as the other parts of the ginseng. This discovery may dramatically improve the efficient of outputs derived from ginseng products. Here, a new technique combining high-performance liquid chromatography (HPLC) with electrospray ionization tandem mass spectrometry (ESI-MS) was employed to identify the fingerprint of P. ginseng fruit. Using HPLC, compounds that are important for medical purposes were extracted and purified. Combined with ESI-MS, the characteristic peaks (nine common peaks) of those compounds were identified, and the accuracy was confirmed by analysis using the Chromatographic Fingerprint Similarity Evaluation System (2004A edition). Overall, 15 batches of ginseng fruit had a similarity of more than 0.80, 13 batches of samples had a similarity between 0.97 and 0.99, and two batches had a similarity less than 0.90. The test solution and mobile phase selection was discussed. The HPLC-ESI-MS method can produce repeatable and reliable results and can be applied in the quality control of P. ginseng fruit.
Collapse
Affiliation(s)
- H F Zhao
- Academy of Chinese Medical Sciences of Jilin Province, Changchun, China
| | - F F Xu
- Jilin Ji'an Yisheng Pharmaceutical Limited by Share Ltd., Ji'an, China
| | - Y T Guo
- Academy of Chinese Medical Sciences of Jilin Province, Changchun, China
| | - H Mi
- Academy of Chinese Medical Sciences of Jilin Province, Changchun, China
| |
Collapse
|
36
|
Chen ZY, Feng YZ, Cui C, Zhao HF, Zhao MM. Effects of koji-making with mixed strains on physicochemical and sensory properties of Chinese-type soy sauce. J Sci Food Agric 2015; 95:2145-2154. [PMID: 25312834 DOI: 10.1002/jsfa.6952] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/21/2014] [Revised: 09/21/2014] [Accepted: 10/08/2014] [Indexed: 06/04/2023]
Abstract
BACKGROUND Two kinds of soy sauces were prepared with Aspergillus oryzae koji (SSAO) and mixed koji (SSAOM, A. oryzae mouldstarter:Monascus purpureus mouldstarter = 1:2, w/w) respectively. The effects of mixed koji on the essential indices, oxygen radical absorption capacity, color indices, free amino acids and volatile compounds of soy sauce have been studied, followed by a sensory evaluation between SSAO and SSAOM. RESULTS The contents of non-salt soluble solid, reducing sugar, total acid, total nitrogen and amino nitrogen in SSAOM increased by 21.50%, 9.88%, 15.35%, 5.98% and 41.43%, respectively, compared with the control SSAO, owing to the higher activities of acid protease and glucoamylase in the mixed koji. Moreover, SSAOM showed higher antioxidant activity, higher levels of free amino acids and much more attractive color. Meanwhile, flavor groups such as esters, aldehydes, pyrazines and sulfur-containing compounds in SSAOM were also improved. The contents of free amino acids and aroma compounds were consistent with the sensory evaluation. According to descriptive sensory analysis, SSAOM showed higher intensity for sweet and umami attributes; in addition, higher flowery, burnt, fruity and caramel-like attributes were perceived in SSAOM, while SSAO showed higher ethanolic and sour attributes. CONCLUSIONS The investigated soy sauce prepared with mixed koji can be considered as an effective method to accelerate the fermentation process and improve the flavor of soy sauce.
Collapse
Affiliation(s)
- Zhi-Yao Chen
- College of Light Industry and Food Science, South China University of Technology, Guangzhou 510640, China
- Sericulture and Agri-food Research Institute, Guangdong Academy of Agricultural Sciences, Guangzhou 510610, China
| | - Yun-Zi Feng
- College of Light Industry and Food Science, South China University of Technology, Guangzhou 510640, China
| | - Chun Cui
- College of Light Industry and Food Science, South China University of Technology, Guangzhou 510640, China
| | - Hai-Feng Zhao
- College of Light Industry and Food Science, South China University of Technology, Guangzhou 510640, China
| | - Mou-Ming Zhao
- College of Light Industry and Food Science, South China University of Technology, Guangzhou 510640, China
| |
Collapse
|
37
|
Xia B, Zhang L, Guo SQ, Li XW, Qu FL, Zhao HF, Zhang LY, Sun BC, You J, Zhang YZ. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma. World J Gastroenterol 2015; 21:2433-2442. [PMID: 25741152 PMCID: PMC4342921 DOI: 10.3748/wjg.v21.i8.2433] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/19/2014] [Revised: 11/06/2014] [Accepted: 12/22/2014] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate whether MYC and BCL-2 coexpression has prognostic significance in primary gastrointestinal diffuse large B-cell lymphoma (PGI-DLBCL) patients, and explore its associations with patients’ clinical parameters.
METHODS: Fresh and paraffin-embedded tumor tissue samples from 60 PGI-DLBCL patients who had undergone surgery at the Tianjin Medical University Cancer Institute and Hospital from January 2005 to May 2010 were obtained, and 30 lymphoid tissue samples from reactive lymph nodes of age- and sex-matched patients represented control samples. Staging and diagnostic procedures were conducted according to the Lugano staging system. All patients had been treated with three therapeutic modalities: surgery, chemotherapy, or radiotherapy. Expression of MYC and BCL-2 were detected at both protein and mRNA levels by immunohistochemistry and real-time RT-PCR.
RESULTS: Positive expression levels of MYC and BCL-2 proteins were detected in 35% and 45% of patients, respectively. MYC+/BCL-2+ protein was present in 30% of patients. MYC and BCL-2 protein levels were correlated with high MYC and BCL-2 mRNA expression, respectively (both P < 0.05). We found that advanced-stage disease (at IIE-IV) was associated with MYC and BCL-2 coexpression levels (P < 0.05). In addition, MYC+/BCL-2+ patients had more difficulty in achieving complete remission than others (P < 0.05). Presence of MYC protein expression only affected overall survival and progression-free survival (PFS) when BCL-2 protein was coexpressed. The adverse prognostic impact of MYC+/BCL-2+ protein on PFS remained significant (P < 0.05) even after adjusting for age, Lugano stage, international prognostic index, and BCL-2 protein expression in a multivariable model.
CONCLUSION: MYC+/BCL-2+ patients have worse chemotherapy response and poorer prognosis than patients who only express one of the two proteins, suggesting that assessment of MYC and BCL-2 expression by immunohistochemistry has clinical significance in predicting clinical outcomes of PGI-DLBCL patients.
Collapse
MESH Headings
- Adult
- Aged
- Biomarkers, Tumor/analysis
- Biomarkers, Tumor/genetics
- Case-Control Studies
- Chi-Square Distribution
- China
- Disease-Free Survival
- Female
- Gastrointestinal Neoplasms/chemistry
- Gastrointestinal Neoplasms/genetics
- Gastrointestinal Neoplasms/mortality
- Gastrointestinal Neoplasms/pathology
- Gastrointestinal Neoplasms/therapy
- Hospitals, University
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Lymphoma, Large B-Cell, Diffuse/chemistry
- Lymphoma, Large B-Cell, Diffuse/genetics
- Lymphoma, Large B-Cell, Diffuse/mortality
- Lymphoma, Large B-Cell, Diffuse/pathology
- Lymphoma, Large B-Cell, Diffuse/therapy
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Staging
- Predictive Value of Tests
- Proportional Hazards Models
- Proto-Oncogene Proteins c-bcl-2/analysis
- Proto-Oncogene Proteins c-bcl-2/genetics
- Proto-Oncogene Proteins c-myc/analysis
- Proto-Oncogene Proteins c-myc/genetics
- RNA, Messenger/analysis
- Real-Time Polymerase Chain Reaction
- Risk Factors
- Time Factors
- Treatment Outcome
- Young Adult
Collapse
|
38
|
Xiao ZY, Li YF, Yao B, Ding ZH, Deng R, Zhao HF, Zhang LG, Zhang ZZ. Significantly enhancing the stability of a Cu2ZnSnS4 aqueous/ethanol-based precursor solution and its application in Cu2ZnSn(S,Se)4 solar cells. RSC Adv 2015. [DOI: 10.1039/c5ra23015b] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
In this work, we report a systematic investigation on the stability of a metal/thiourea aqueous/ethanol-based precursor solution used for fabricating Cu2ZnSnS4 (CZTS) thin films.
Collapse
Affiliation(s)
- Zhen-Yu Xiao
- Key Laboratory of Physics and Technology for Advanced Batteries (Ministry of Education)
- College of Physics
- Jilin University
- Changchun
- China
| | - Yong-Feng Li
- Key Laboratory of Physics and Technology for Advanced Batteries (Ministry of Education)
- College of Physics
- Jilin University
- Changchun
- China
| | - Bin Yao
- Key Laboratory of Physics and Technology for Advanced Batteries (Ministry of Education)
- College of Physics
- Jilin University
- Changchun
- China
| | - Zhan-Hui Ding
- State Key Lab of Superhard Materials
- College of Physics
- Jilin University
- Changchun 130012
- China
| | - Rui Deng
- School of Materials Science and Engineering
- Changchun University of Science and Technology
- Changchun
- China
| | - Hai-Feng Zhao
- State Key Laboratory of Luminescence and Applications
- Changchun Institute of Optics, Fine Mechanics and Physics
- Chinese Academy of Sciences
- Changchun 130033
- PR China
| | - Li-Gong Zhang
- State Key Laboratory of Luminescence and Applications
- Changchun Institute of Optics, Fine Mechanics and Physics
- Chinese Academy of Sciences
- Changchun 130033
- PR China
| | - Zhen-Zhong Zhang
- State Key Laboratory of Luminescence and Applications
- Changchun Institute of Optics, Fine Mechanics and Physics
- Chinese Academy of Sciences
- Changchun 130033
- PR China
| |
Collapse
|
39
|
Song LN, Li LX, Shi QH, Fang L, Sun L, Zhao HF, Liu N, Li HJ, He CY. Periostin as a promising target of therapeutical intervention for colorectal cancer. BANGL J PHARMACOL 2014. [DOI: 10.3329/bjp.v9i4.19921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
40
|
Lü SS, Fang X, Wang JQ, Fang F, Zhao HF, Chu XY, Li JH, Fang D, Tang JL, Wei ZP, Ma XH, Wang XH, Pu SS, Xu L. [Preparation of MgxZn1-xO/Au/MgxZn1-xO multilayer transparent conductive film and studies of its photoelectric properties]. Guang Pu Xue Yu Guang Pu Fen Xi 2014; 34:2355-2359. [PMID: 25532325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
In the present paper, MgxZn1-xO and MgxZn1-xO/Au/MgxZn1-xO multilayer structures of transparent conductive film were prepared by the simple operation of sol-gel and RF magnetron sputtering method on quartz substrate respectively and then they were annealed. The surface, electrical, crystal and optical properties of the films at different annealing temperature were determined by UV-Vis spectrophotometer, X-ray diffraction, photoluminescence and Hall effect, respectively. The influence of annealing temperature on the films was also investigated. The testing results indicated that the films with good c-axis orientation presented hexagonal wurtzite structure. With increasing Mg components, the optical band gap of ZnO thin film increased gradually. There was an obvious blue shift phenomenon in PL spectrum and absorption spectrum line. But the electrical properties of the films declined. In MgxZn1-xO/Au/MgxZn1-xO multilayer structure of thin film samples, the existence of Au interlining led to the poor optical properties of thin film, and the light transmittance in the ultraviolet region was 60%. Compared with MgxZn1-xO film, the electrical properties of MgxZn1-xO/Au/MgxZn1-xO multilayer structure of transparent conductive film were improved, the resistivity and migration rate were significantly increased. In addition, high temperature annealing treatment could effectively improve the crystal quality of thin film and further improve the electrical characteristics of the samples. After the annealing treatment at 500 °C, migration rate of the film reached to 40.9 cm2 · 1 Vs(-1) while the resistivity was 0.0057 Ω · cm. Due to the rising of temperature, the crystal size increased from 25.1 to 32.4 nm to reduce the mobility of the film. Therefore, MgxZn1-xO/Au/MgxZn1-xO multilayer structure of transparent conductive film played an important role in promoting the ZnO transparent conductive film application in deep ultraviolet devices.
Collapse
|
41
|
Liu XY, Shan CX, Jiao C, Wang SP, Zhao HF, Shen DZ. Pure ultraviolet emission from ZnO nanowire-based p-n heterostructures. Opt Lett 2014; 39:422-425. [PMID: 24487830 DOI: 10.1364/ol.39.000422] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Well-aligned ZnO nanowires have been prepared on sapphire substrate, and structural and optical characterizations indicate that the nanowires are of single crystalline and have relatively high luminescent quality. By employing the ZnO nanowires as an active layer, p-Zn0.68Mg0.32O:N/n-ZnO nanowire heterostructure light-emitting devices (LEDs) have been fabricated. The LEDs show pure ultraviolet emission when a forward bias is applied, while the deep-level emission frequently observed in ZnO p-n junctions is almost totally invisible. The devices can work continuously for over 27 h under the injection of a current density of 500 mA/cm2, indicating their good stability.
Collapse
|
42
|
Cui C, Lei FF, Wang YR, Zhao HF, Sun WZ, You LJ. Antioxidant Properties of Maillard Reaction Products from Defatted Peanut Meal Hydrolysate-Glucose Syrup and its Application to Sachima. FSTR 2014. [DOI: 10.3136/fstr.20.327] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
43
|
Jin X, Zhao HF, Yu Y, Zhao DD, Yang HL, Wang XF, Zhao ZG, Wang YF, Wu XX, Da WM, Zhang YZ. Analysis of clinical characteristics and prognostic factors of primary mediastinal T-cell lymphoblastic lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013; 21:377-82. [PMID: 23628036 DOI: 10.7534/j.issn.1009-2137.2013.02.024] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Lymphoblastic lymphoma (LBL) comprises 2% to 4% of non-Hodgkin lymphomas cases in adults, of which 85% to 90% of LBL in adults is of T-cell phenotype. This study was aimed to evaluate the clinical characteristics and prognostic factors of patients with mediastinal T-LBL. Based on the retrospective analysis of the clinical data of 35 patients with mediastinal T-LBL during the period from January 1998 to January 2011, the clinical characteristics and prognostic factors of mediastinal T-LBL were summarized. The results showed that the total of 35 patients were identified (male 24 and female 11), with a median age of 19 (5 - 52) years. The majority of patients were in stage III/IV, 16 cases (45.7%) presented bulky mediastinal mass. Intrathoracic effusions (pleural, pericardial) were not uncommon (62.9%). Overall survival rate (OS) and progression-free survival rate (PFS) at 3 years for the entire cohort were 36% and 24%, respectively. OS and PFS at 5 years were 25% and 16.7%, respectively. Anemia at diagnosis were an important, independent predictor of OS (P = 0.048). Bulky mass (P = 0.048), superior vena cava syndrome (P = 0.021), and abnormal PLT count at diagnosis was the independent prognostic factors for PFS (P = 0.021). It is concluded that the patients with primary mediastinal T-LBL are characterized by a low incidence, bad prognosis, and short survival. For patients accompanying with anemia, bulky mass and superior vena cava syndrome, their prognosis is worse.
Collapse
Affiliation(s)
- Xin Jin
- Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Abstract
Zinc oxide (ZnO) nanocolumns have been prepared by a metal-organic chemical vapor deposition technique, and structural and optical characterization reveal that the nanocolumns have high crystalline and luminescent qualities. Au/MgO/ZnO/In structured Schottky diodes have been fabricated from the nanocolumns. An intense emission can be detected from the diodes under the drive of bias voltage, and the output power can reach 3.7 μW. The intense emission comes from both the high crystalline and luminescent qualities of the ZnO nanocolumns, and the ideal Schottky contact formed in the Au/MgO/ZnO/In structures.
Collapse
Affiliation(s)
- Xing-Yu Liu
- State Key Laboratory of Luminescence and Applications, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences, Changchun, China
| | | | | | | | | |
Collapse
|
45
|
Xu C, Jiang XZ, Zhao HF, Zhang NZ, Ma L, Xu ZS. The applicability of Ki-67 marker for renal epithelioid angiomyolipoma: experience of ten cases from a single center. Neoplasma 2013; 60:209-14. [PMID: 23259791 DOI: 10.4149/neo_2013_028] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
In order to present our experience with 10 cases of renal epithelioid angiomyolipoma (EAML) and validate the applicability of Ki-67 (proliferation marker) for EAML, we reviewed medical records of 10 consecutive cases diagnosed EAML from January 2005 to February 2012 at our department. Clinical data were collected and analyzed and pathology slides were reviewed. The immunohistochemical reactions for Ki-67 were performed and tumors showed positive expression were estimated. Active follow-up was performed to investigate the association between Ki-67 expression and the prognosis. The mean age and tumor size of the patients was 43.6 years (range 32-56) and 8.2 cm (range 2-15 cm), respectively. Seven were females while three were males. Radical nephrectomy was performed in 6 patients, partial nephrectomy in 3, and renal artery ligation in 1. The immunohistochemical reactions for HMB-45 (Human Melanoma Black), SMA (Smooth Muscle Actin) were positive but for S-100 were negative. The number of patients showing positive/negative Ki-67 expression was 5/5. The survival rate of the positive group was 20% (1/5) while 100% (5/5) of the negative group during the median follow-up time of 26.75 months (range 1-53). Recurrence, metastasis and death due to disease occurred in 1 (10%), 3 (30%) and 4 (40%) patients, respectively. Higher expression (positive) of Ki-67 indicates the presence of EAML and poor prognosis of patients. Surgical excision including radical and partial nephrectomy is a considerable approach to the treatment for its malignant potential.
Collapse
Affiliation(s)
- C Xu
- Department of Urology, Qilu Hospital of Shandong University, Jinan, China
| | | | | | | | | | | |
Collapse
|
46
|
Xia B, Guo Q, Zhao DD, Zhao HF, Han XP, Wang H, Wu XX, Zhang YZ. Significance of CD34(-) and CD34(+) cell apoptosis and proliferation in bone marrow of patients with MDS and their impact on survival. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012; 20:1392-1397. [PMID: 23257440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Alteration in the balance between cell apoptosis and proliferation is one of the pathophysiological mechanisms of the myelodysplastic syndromes (MDS). The question of whether the excessive apoptosis and/or proliferation predominantly involve the subset of progenitor cells (CD34(+) cells) or mature cells (CD34(-) cells) remains a controversial issue. This study was purpose to analyze the apoptosis and proliferation status of CD34(+) and CD34(-) cells in bone marrow (BM) of patients with MDS, to investigate the pathogenesis of MDS and to determine the relation of apoptosis and proliferation status of CD34(+) and CD34(-) cells with prognosis of MDS. The proportion of CD34(+) cells, the apoptosis and proliferation ratio (A/P) of CD34(+) and CD34(-) cells in BM of 40 patients with MDS, including 20 cases of high-risk MDS and 20 cases of low-risk MDS, and 10 normal persons as control were detected by flow cytometry; the influence of CD34(+) and CD34(-) cell apoptosis and proliferation levels on prognosis of MDS was evaluated by univariate and multivariate analysis of survival. The results showed that the proportion of CD34(+) cells in BM of high-risk MDS patients was significantly higher than that in BM of low-risk MDS patients and in normal BM [(1.92 ± 0.10)%, (1.09 ± 0.04)%, (1.03 ± 0.05)% respectively]. The apoptotic rates (AR) of both CD34(+) and CD34(-) cells were significantly higher in low-risk MDS [(54.75 ± 2.18)%, (80.36 ± 1.68)%] than in high-risk MDS [(24.87 ± 2.69)%, (23.12 ± 1.23)%] and in normal BM [(18.51 ± 2.74)%, (20.98 ± 2.21)%]. When compared between CD34(+) cells and CD34(-) cells in low-risk MDS, a greater AR of CD34(-) cells was found. However, the higher proliferative rate of CD34(+) cells was observed in high-risk MDS. In low-risk MDS, a higher A/P ratio was found in CD34(-) cells than in CD34(+) cells; whereas this ratio was equalized or inverted in high-risk MDS. In addition, the survival and prognosis correlated significantly with AR of CD34(+) cells. It is concluded that the early MDS is predominantly associated with excessive apoptosis of the mature CD34(-) cells. The proliferation rate of cells increases with the disease progression in MDS subsets, especially, in the subset of CD34(+) cells. Surprisingly, the apoptosis of CD34(+) cells may be a useful prognostic factor, and the inhibition of apoptotic mechanisms may induce the transformation of MDS to leukemia.
Collapse
Affiliation(s)
- Bing Xia
- Department of Hematology, Cancer Hospital of Tianjin Medical University, Tianjin Key Laboratory of Tumor Prevention and Therapy, Tianjin 300060, China
| | | | | | | | | | | | | | | |
Collapse
|
47
|
Fang Z, Zhang YZ, Cai T, Li KQ, Yu J, Luo YQ, Zhao HF. [Expression of transforming growth factor-β1 and its receptors in peripheral blood of patients with immune thrombocytopenic purpura]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012; 20:664-666. [PMID: 22739178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
This study was purposed to detect the expression of transforming growth factor β1 (TGF-β1) and its receptors (TGF-βR) and to investigate their roles in pathogenesis of immune thrombocytopenic purpura (ITP). The expressions of TGF-β1 and their receptors TGF-βRI, TGF-βRII and TGF-βRIII in the peripheral blood of patients with ITP and healthy persons were detected by the real-time PCR, and differences of their expression levels were analysed. The results showed that the expression of TGF-β1 and TGF-βRII mRNA in ITP patients was significantly higher than that in the healthy controls, while the TGF-βRI mRNA expression in ITP patient was significantly lower than that in the controls. The expression of TGF-βRIII was not statistically different between the two groups. It is concluded that TGF-β1 and its receptors including TGF-βRI and TGF-βRII express abnormally in the peripheral blood of ITP patients, which suggests that the TGF-β signaling pathway probably play a vital role in the pathogenesis of the ITP.
Collapse
Affiliation(s)
- Zhi Fang
- Department of Hematology and Oncology, Ningbo Municipal Second Hospital, Zhejiang Province, China
| | | | | | | | | | | | | |
Collapse
|
48
|
Zhang YZ, Zhao DD, Zhao WP, Zhao HF, Zhao ZG, Wang YF, Wu XX, Han XP, Da WM. [Experimental study of SHP-1 promoter methylation in myelodysplastic syndromes and its related mechanism]. Zhonghua Xue Ye Xue Za Zhi 2012; 33:108-112. [PMID: 22730659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
OBJECTIVE To explore the role of SHP-1 promoter methylation on the pathogenesis and progression in myelodysplastic syndromes (MDS) and its related mechanism. METHODS 63 MDS patients were divided into low-grade (LG) group and high-grade (HG) group according to IPSS score system. Bone marrow samples were collected. Methylation specific-PCR (MSP) were used to detect the status of SHP-1 promoter methylation in bone marrow (BM) samples from different risk MDS patients and MDS cell line, SKK-1. Western blot was used to detect signal transduction and activator of transcription (STAT3) activation in SKK-1 cell line and MDS patients. RESULTS No SHP-1 promoter methylation could be detected in healthy controls BM. Partially methylation was found in SKK-1 cell line. Methylation rate of SHP-1 gene promoter was found in BM of 24.2% of low-grade MDS patients and 63.3% of high-grade MDS patients, the difference between these two groups was statistically significant (P < 0.05); Patients were divided into different groups according to WHO subtype, chromosomal karyotype and blast cells in bone marrow, methylation rates of SHP-1 were significantly higher in RAEB-II, poor karyotype group and samples with 0.11-0.19 blast cells (P < 0.05); The phosphorylation protein of STAT3 was detected in SKK-1 cell line. The expression of phosphorylation STAT3 was significantly higher in HG group than in LG group (66.7% vs 18.2%) (P < 0.05). There was a significant correlation between SHP-1 promoter methylation and STAT3 phosphorylation. CONCLUSION Abnormal methylation of SHP-1 gene promoter might have tentative role in the pathogenesis and progression of MDS, which may be involved in STAT3 activation. Detection of SHP-1 promoter methylation may be helpful to evaluate the prognosis of MDS.
Collapse
Affiliation(s)
- Yi-Zhuo Zhang
- Department of Hematology, General Hospital of People's Liberation Army, Beijing 100853, China
| | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Zhi YQ, Zhang YZ, Zhao HF, Zhao DD, Xia B, Wu XX, Da WM. [Correlation of stromal cell derived factor-1 with angiogenesis and cell apoptosis in myelodysplastic syndromes]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011; 19:1438-1442. [PMID: 22169299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
The study was aimed to investigate the expression of stromal cell derived factor (SDF-1) in bone marrow (BM) and its relation with apoptosis of BM CD34(+) cell and angiogenesis in myelodysplastic syndrome (MDS). 40 patients with MDS were divided into low-risk group and high-risk group according to IPSS score system. BM samples were collected. SDF-1 levels, the apoptosis of CD34(+) cells and microvessel density (MVD) of BM were detected by ELISA, flow cytometry and immunochemistry, respectively. The results showed that the SDF-1 level in MDS patients was significantly higher than that in normal controls(p < 0.05), and SDF-1 level in low-risk group was significantly higher than that in high-risk group. Apoptosis of CD34(+) cells significantly increased in low-risk group compared with other groups (p < 0.05). MVD in BM biopsy significantly increased in high-risk MDS group (p < 0.05), compared with low-risk MDS group which also had higher MVD than the control group (p < 0.05). Positive correlation was found between apoptosis of CD34(+) cells and SDF-1 levels in low-risk group, and SDF-1 level and MVD in high-risk group. It is concluded that the expression of SDF-1, apoptosis of BM CD34(+) cells and MVD were significantly abnormal in MDS patients, especially in different risk group, suggesting that SDF-1 level is related to cell apoptosis and angiogenesis.
Collapse
Affiliation(s)
- Ya-Qin Zhi
- Department of Hematology, Tianjin Medical University Cancer Hospital, Tianjin, China
| | | | | | | | | | | | | |
Collapse
|
50
|
Zhao HF, Li Q, Li Y. Long-term ginsenoside administration prevents memory loss in aged female C57BL/6J mice by modulating the redox status and up-regulating the plasticity-related proteins in hippocampus. Neuroscience 2011; 183:189-202. [PMID: 21463662 DOI: 10.1016/j.neuroscience.2011.03.048] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2010] [Revised: 03/22/2011] [Accepted: 03/22/2011] [Indexed: 12/13/2022]
Abstract
Memory impairment is considered to be one of the most prominent consequences of aging. Deterioration of memory begins in advance of old age in animals, including humans. The generation of reactive oxygen species (ROS) and/or free radicals-induced oxidative stress which is the major age-related changes, can lead to hippocampus damage and increase vulnerability to impaired learning and memory. Ginsenoside, the effective ingredient of ginseng, has been reported to have a neuron beneficial effect. In the present study, C57BL/6J mice aged 12 months were chronically treated with ginsenoside (three dose groups were given ginsenoside in drinking water for 8 months, the concentration of ginsenoside in drinking water was 0.028%, 0.056%, and 0.112% (w/v), respectively). Placebo-treated aged mice and young ones (4 months old) were used as controls. The efficacious effect of ginsenoside was manifested in the amelioration of memory impairment in aged mice by Morris water maze and step-down tests. Total superoxide dismutase (T-SOD), glutathione peroxidase (GSH-Px), and thiobarbituric acid reactive substances (TBARS) have been used as the biomarkers of oxidative stress. In ginsenoside treated groups, the activities of T-SOD and GSH-Px markedly increased, and the levels of TBARS and the content of protein carbonyl decreased significantly in serum and in hippocampus. The activation of lipofuscin formation, disruption or loss of cristae in mitochondria, the irregular nucleus and condensed chromatin laid against the nuclear membrane in pyramidal cells of hippocampal CA1 region, which are all related to oxidative stress, were also reduced after ginsenoside treatment. Processes of memory formation and functional plasticity are associated with postsynaptic density-95 (PSD-95), protein kinase Cγ subunit (PKCγ) and brain derived neurotrophic factor (BDNF). In the present study, we found that long-term ginsenoside treatment prevented age-related reductions of PSD-95, PKCγ, and BDNF in the hippocampus. These results demonstrated that long-term ginsenoside administration may prevent memory loss in aged C57BL/6J mice by modulating the redox status and up-regulating the plasticity-related proteins in hippocampus.
Collapse
Affiliation(s)
- H F Zhao
- Department of Nutrition and Food Hygiene, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China
| | | | | |
Collapse
|